BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy12785
(194 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 75.1 bits (183), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+A E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTAAEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 74.7 bits (182), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 42/119 (35%), Positives = 67/119 (56%), Gaps = 8/119 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
RIVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 15 RIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR 72
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 73 --NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 127
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 73.2 bits (178), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 42/118 (35%), Positives = 64/118 (54%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG + G PWQA + CGG+++N F+V+TA HC+ +A ++ V +GD
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQA--KRFTVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V H +F + +D+AVLRL P+++ ++AP CLPEK
Sbjct: 58 -NTEQEEGNEMAHEVEMTVKHS--RFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEK 112
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 72.4 bits (176), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 41/118 (34%), Positives = 66/118 (55%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG E G PWQA + CGG++++ F+++TA HC+ +A ++ +V +GD
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQA--KRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N+ E V + H +FT + +D+AVLRL P+ + ++AP CLPE+
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPACLPER 112
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 71.2 bits (173), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 19/167 (11%)
Query: 15 LYACCHRNTAKASDHHE-IPQPLNYGPVQNDPRCGVSVKNQGAQRRIVGGDEAGFGSFPW 73
+Y C + K E IP+ L P CG V ++RI+GG +A G+FPW
Sbjct: 52 VYTCTAQGIWKNEQKGEKIPRCL--------PVCGKPVNPVEQRQRIIGGQKAKMGNFPW 103
Query: 74 QAYIRIGSSRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLGDYVINSAVEPLPAY-TFG 131
Q + I R GG+L+ ++TA H + + Q +L ++ ++ VE L
Sbjct: 104 QVFTNI-HGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHP 162
Query: 132 VRKINVHPYFKFTPQADRY----DVAVLRLDRPVQYMPHIAPICLPE 174
+R+++VHP ++ Q + Y D+A+L L+ V P++ PICLP+
Sbjct: 163 IRRVSVHPDYR---QDESYNFEGDIALLELENSVTLGPNLLPICLPD 206
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 71.2 bits (173), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 19/167 (11%)
Query: 15 LYACCHRNTAKASDHHE-IPQPLNYGPVQNDPRCGVSVKNQGAQRRIVGGDEAGFGSFPW 73
+Y C + K E IP+ L P CG V ++RI+GG +A G+FPW
Sbjct: 52 VYTCTAQGIWKNEQKGEKIPRCL--------PVCGKPVNPVEQRQRIIGGQKAKMGNFPW 103
Query: 74 QAYIRIGSSRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLGDYVINSAVEPLPAY-TFG 131
Q + I R GG+L+ ++TA H + + Q +L ++ ++ VE L
Sbjct: 104 QVFTNI-HGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLGHTNVEELMKLGNHP 162
Query: 132 VRKINVHPYFKFTPQADRY----DVAVLRLDRPVQYMPHIAPICLPE 174
+R+++VHP ++ Q + Y D+A+L L+ V P++ PICLP+
Sbjct: 163 IRRVSVHPDYR---QDESYNFEGDIALLELENSVTLGPNLLPICLPD 206
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 71.2 bits (173), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 53/139 (38%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 47 CGVSVKNQGAQR-RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARAS 105
CG K + R RI+GG + GS PW A I IG S C GSLV+ VV+A HC + +
Sbjct: 22 CGRRHKKRTFLRPRIIGGSSSLPGSHPWLAAIYIGDSFCAGSLVHTCWVVSAAHCFSHSP 81
Query: 106 ARQ-VQVTLGDYVINSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRL----DR 159
R V V LG + N + TFG+ K I Y F P +D+ ++RL DR
Sbjct: 82 PRDSVSVVLGQHFFNRTTD--VTQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDR 137
Query: 160 PVQYMPHIAPICLPEKGKS 178
+ PICLPE G +
Sbjct: 138 CATRSQFVQPICLPEPGST 156
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 70.1 bits (170), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 44 DPRCGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGH 99
D C +K RIVGG + G +PWQ + S CGGS++ ++TA H
Sbjct: 377 DNECTTKIKP-----RIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAH 431
Query: 100 CVARASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDR 159
C + ++ + S ++ ++ FGV++I +H +K YD+A+L+L+
Sbjct: 432 CFYGVESPKILRVYSGILNQSEIKEDTSF-FGVQEIIIHDQYKMAESG--YDIALLKLET 488
Query: 160 PVQYMPHIAPICLPEKGKSTCI 181
V Y PICLP KG I
Sbjct: 489 TVNYTDSQRPICLPSKGDRNVI 510
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 69.7 bits (169), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 51/150 (34%), Positives = 77/150 (51%), Gaps = 29/150 (19%)
Query: 47 CGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSSR------CGGSLVNRFHVVTAGHC 100
CG V+ +I+ GD+ FPW A I +S CGGSL+N ++VTA HC
Sbjct: 14 CGYQVEAD----KILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHC 69
Query: 101 VARASARQV----QVTLGDYVINSAVEP---------LPA--YTFGVRKINVHPYFKFTP 145
VA R V +V LG++ N+A +P +P G+ + HP +
Sbjct: 70 VAGRVLRVVGALNKVRLGEW--NTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDY-VDG 126
Query: 146 QADRY-DVAVLRLDRPVQYMPHIAPICLPE 174
DRY D+A++RL+R V++ +I P+CLP+
Sbjct: 127 SKDRYHDIALIRLNRQVEFTNYIRPVCLPQ 156
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 68.9 bits (167), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 43/136 (31%), Positives = 74/136 (54%), Gaps = 10/136 (7%)
Query: 45 PRCGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCV-AR 103
P CG V +++I+GG +A G+FPWQ + I R GG+L+ ++TA H + +
Sbjct: 143 PVCGKPVNPVEQRQQIIGGQKAKMGNFPWQVFTNI-HGRGGGALLGDRWILTAAHTLYPK 201
Query: 104 ASARQVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRY----DVAVLRLD 158
Q +L ++ ++ VE L +R+++VHP ++ Q + Y D+A+L L+
Sbjct: 202 EHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYR---QDESYNFEGDIALLELE 258
Query: 159 RPVQYMPHIAPICLPE 174
V P++ PICLP+
Sbjct: 259 NSVTLGPNLLPICLPD 274
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 68.6 bits (166), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 17/131 (12%)
Query: 58 RRIVGGDEAGFGSFPWQAYIR---IGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVT 112
+R+ G E S PW A +R G SR CGG++++ +++TA HCV ++
Sbjct: 117 QRVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVHGLQNDLYEIR 176
Query: 113 LGDYVINSAVE----------PLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 162
LG++ I++ + P G+ K +H K+ + +D+A+L+L+R V
Sbjct: 177 LGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHE--KYDARHIMHDIALLKLNRSVP 234
Query: 163 YMPHIAPICLP 173
+ HI PICLP
Sbjct: 235 FQKHIKPICLP 245
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 68.6 bits (166), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/125 (38%), Positives = 63/125 (50%), Gaps = 10/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQ-VQVTLGDYVI 118
I+GG + GS PW A I IG S C GSLV+ VV+A HC + + R V V LG +
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFF 60
Query: 119 NSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIAPICLP 173
N + TFG+ K I Y F P +D+ ++RL DR + PICLP
Sbjct: 61 NRTTD--VTQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDRCATRSQFVQPICLP 116
Query: 174 EKGKS 178
E G +
Sbjct: 117 EPGST 121
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 68.6 bits (166), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/125 (38%), Positives = 63/125 (50%), Gaps = 10/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQ-VQVTLGDYVI 118
I+GG + GS PW A I IG S C GSLV+ VV+A HC + + R V V LG +
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFF 60
Query: 119 NSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIAPICLP 173
N + TFG+ K I Y F P +D+ ++RL DR + PICLP
Sbjct: 61 NRTTD--VTQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDRCATRSQFVQPICLP 116
Query: 174 EKGKS 178
E G +
Sbjct: 117 EPGST 121
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 68.2 bits (165), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 39/126 (30%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
IVGG + G +PWQ + S CGGS++ ++TA HC + ++
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ S ++ ++ FGV++I +H +K YD+A+L+L+ V Y PICLP K
Sbjct: 61 ILNQSEIKEDTSF-FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPICLPSK 117
Query: 176 GKSTCI 181
G I
Sbjct: 118 GDRNVI 123
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 68.2 bits (165), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 43/127 (33%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLG 114
IVGG + G +PWQ + S CGGS++ ++TA HC S + ++V G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
++N A FGV++I +H +K YD+A+L+L+ V Y PICLP
Sbjct: 61 --ILNQAEIKEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPICLPS 116
Query: 175 KGKSTCI 181
KG I
Sbjct: 117 KGDRNVI 123
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 68.2 bits (165), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 43/127 (33%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLG 114
IVGG + G +PWQ + S CGGS++ ++TA HC S + ++V G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
++N A FGV++I +H +K YD+A+L+L+ V Y PICLP
Sbjct: 61 --ILNQAEIKEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPICLPS 116
Query: 175 KGKSTCI 181
KG I
Sbjct: 117 KGDRNVI 123
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 67.8 bits (164), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 43/127 (33%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLG 114
IVGG + G +PWQ + S CGGS++ ++TA HC S + ++V G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
++N A FGV++I +H +K YD+A+L+L+ V Y PICLP
Sbjct: 61 --ILNQAEIAEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPICLPS 116
Query: 175 KGKSTCI 181
KG I
Sbjct: 117 KGDRNVI 123
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 67.0 bits (162), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 43/122 (35%), Positives = 67/122 (54%), Gaps = 9/122 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSS-----RCGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
+VGG++A S+PWQ ++ SS CGG+LV++ V+TA HC+ +S+R +V LG
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCI--SSSRTYRVVLG 58
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ + S EP + V K+ VH + ++ D+A+L+L PV I CLP
Sbjct: 59 RHSL-STNEP-GSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCLPA 116
Query: 175 KG 176
G
Sbjct: 117 AG 118
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 67.0 bits (162), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 41/126 (32%), Positives = 64/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T+ D
Sbjct: 49 RIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTVDD 107
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y V KI+ +HP + + DR D+A+L+L RP++ +I P
Sbjct: 108 LLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHP 166
Query: 170 ICLPEK 175
+CLP+K
Sbjct: 167 VCLPDK 172
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 66.6 bits (161), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG+ A G FPWQ + + CGGS++N VVTA HC+ ++ V G+Y
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIE--PGVKITVVAGEYN- 57
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
EP +R I H Y T +D+A+L LD P+ ++ PIC+ +K
Sbjct: 58 TEETEPTEQRRNVIRAIPHHSY-NATVNKYSHDIALLELDEPLTLNSYVTPICIADK 113
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 66.2 bits (160), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 40/125 (32%), Positives = 63/125 (50%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T+ D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTVDDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y V KI+ +HP + + DR D+A+L+L RP++ +I P+
Sbjct: 60 LVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHPV 118
Query: 171 CLPEK 175
CLP+K
Sbjct: 119 CLPDK 123
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 65.5 bits (158), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 45/143 (31%), Positives = 74/143 (51%), Gaps = 15/143 (10%)
Query: 47 CGVSVKNQGAQRRIVG-GDEAGFGSFPW-----QAYIRIGSSR----CGGSLVNRFHVVT 96
CG+ +G +I G +EA +G FPW +A + GS CGGSL+ V+T
Sbjct: 118 CGIR-NERGLDFKITGQTNEAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLT 176
Query: 97 AGHCVA--RASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAV 154
HCV +++ +++ G++ + E LP +R++ +H F P+ DVA+
Sbjct: 177 GAHCVNSYQSNLDAIKIRAGEWDTLTEKERLPYQERKIRQVIIHS--NFNPKTVVNDVAL 234
Query: 155 LRLDRPVQYMPHIAPICLPEKGK 177
L LDRP+ +I ICLP++ +
Sbjct: 235 LLLDRPLVQADNIGTICLPQQSQ 257
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 65.5 bits (158), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 46/123 (37%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSS---RCGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
+VGG EA S+P Q + R GSS CGG+L+ + V+TA HCV R +V V
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ N+ E GV+KI VHPY+ A YD+A+LRL + V ++ LP
Sbjct: 61 NLNQNNGTEQY----VGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPR 116
Query: 175 KGK 177
G
Sbjct: 117 AGT 119
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 65.5 bits (158), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 46/122 (37%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSS---RCGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
+VGG EA S+P Q + R GSS CGG+L+ + V+TA HCV R +V V
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ N+ E GV+KI VHPY+ A YD+A+LRL + V ++ LP
Sbjct: 61 NLNQNNGTEQY----VGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPR 116
Query: 175 KG 176
G
Sbjct: 117 AG 118
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 65.5 bits (158), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 40/125 (32%), Positives = 63/125 (50%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T+ D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTVDDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y V KI+ +HP + + DR D+A+L+L RP++ +I P+
Sbjct: 60 LVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHPV 118
Query: 171 CLPEK 175
CLP+K
Sbjct: 119 CLPDK 123
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 65.1 bits (157), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 40/125 (32%), Positives = 63/125 (50%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T+ D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTVDDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y V KI+ +HP + + DR D+A+L+L RP++ +I P+
Sbjct: 60 LVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHPV 118
Query: 171 CLPEK 175
CLP+K
Sbjct: 119 CLPDK 123
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 65.1 bits (157), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
IVGG + G +PWQ + S CGGS++ ++TA HC + ++
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ S ++ ++ FGV++I +H +K YD+A+L+L+ V Y PI LP K
Sbjct: 61 ILNQSEIKEDTSF-FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPISLPSK 117
Query: 176 GKSTCI 181
G+ I
Sbjct: 118 GERNVI 123
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 65.1 bits (157), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 46/123 (37%), Positives = 62/123 (50%), Gaps = 9/123 (7%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSS---RCGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
+VGG EA S+P Q + R GSS CGG+L+ + V+TA HCV R +V V
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ N E GV+KI VHPY+ A YD+A+LRL + V ++ LP
Sbjct: 61 NLNQNDGTEQY----VGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPR 116
Query: 175 KGK 177
G
Sbjct: 117 AGT 119
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/134 (29%), Positives = 69/134 (51%), Gaps = 10/134 (7%)
Query: 45 PRCGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARA 104
P CGV + ++RI+GG +A +FPWQ + + GG+L+N + V+TA H V
Sbjct: 68 PVCGVPREPFEEKQRIIGGSDADIKNFPWQVFFD--NPWAGGALINEYWVLTAAHVV--E 123
Query: 105 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKF--TPQADR---YDVAVLRLDR 159
R+ + +G + ++ + + +HP +K P+ D+A++RL
Sbjct: 124 GNREPTMYVGSTSVQTS-RLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDIALVRLKD 182
Query: 160 PVQYMPHIAPICLP 173
PV+ P ++PICLP
Sbjct: 183 PVKMGPTVSPICLP 196
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 17/131 (12%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
IVGG E+ +G +PWQ +++ + CGGSL+ V+TA HC + V
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDV------ 54
Query: 116 YVINSAVEPLPAYTFG-----VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
+ I S + L T +++I +H +K + +D+A+++L P++Y PI
Sbjct: 55 WRIYSGILELSDITKDTPFSQIKEIIIHQNYKVSE--GNHDIALIKLQAPLEYTEFQKPI 112
Query: 171 CLPEKGKSTCI 181
LP KG ++ I
Sbjct: 113 SLPSKGDTSTI 123
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 60/118 (50%), Gaps = 6/118 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVAR-ASARQVQVTLGDYV 117
IVGG + G PWQ + + G+ CGG+L+N VV+A HC + + R + LG++
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
++ R V + P +D+A+LRL +PV H+ P+CLPE+
Sbjct: 61 LSEH----DGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPER 114
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/122 (31%), Positives = 67/122 (54%), Gaps = 10/122 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVA-RASARQVQVTLGDYVI 118
I+GG +A G+FPWQ + I R GG+L+ ++TA H + + Q +L ++
Sbjct: 1 IIGGQKAKMGNFPWQVFTNI-HGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFLG 59
Query: 119 NSAVEPLPAY-TFGVRKINVHPYFKFTPQADRY----DVAVLRLDRPVQYMPHIAPICLP 173
++ VE L +R+++VHP ++ Q + Y D+A+L L+ V P++ PICLP
Sbjct: 60 HTNVEELMKLGNHPIRRVSVHPDYR---QDESYNFEGDIALLELENSVTLGPNLLPICLP 116
Query: 174 EK 175
+
Sbjct: 117 DN 118
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLG 114
IVGG + G +PWQ + S CGGS++ ++TA HC S + ++V G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
++N A FGV++I +H +K YD+A+L+L+ V Y PI LP
Sbjct: 61 --ILNQAEIKEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPISLPS 116
Query: 175 KGKSTCI 181
KG I
Sbjct: 117 KGDRNVI 123
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
IVGG + G +PWQ + S CGGS++ ++TA HC + ++
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ S ++ ++ FGV++I +H +K YD+A+L+L+ V Y PI LP K
Sbjct: 61 ILNQSEIKEDTSF-FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPISLPSK 117
Query: 176 GKSTCI 181
G I
Sbjct: 118 GDRNVI 123
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/120 (33%), Positives = 63/120 (52%), Gaps = 11/120 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+VGG++A G FPWQ + + CGGS+VN +VTA HCV + ++ V G++ I
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCV--ETGVKITVVAGEHNI 58
Query: 119 NSAVEPLPAYTFGVRK-INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEK 175
+T R I + P+ F + Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 59 EET-----EHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADK 113
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/120 (33%), Positives = 63/120 (52%), Gaps = 11/120 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+VGG++A G FPWQ + + CGGS+VN +VTA HCV + ++ V G++ I
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCV--ETGVKITVVAGEHNI 58
Query: 119 NSAVEPLPAYTFGVRK-INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEK 175
+T R I + P+ F + Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 59 EET-----EHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADK 113
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLG 114
IVGG + G +PWQ + S CGGS++ ++TA HC S + ++V G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
++N A FGV++I +H +K YD+A+L+L+ V Y PI LP
Sbjct: 61 --ILNQAEIAEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPISLPS 116
Query: 175 KGKSTCI 181
KG I
Sbjct: 117 KGDRNVI 123
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLG 114
IVGG + G +PWQ + S CGGS++ ++TA HC S + ++V G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
++N A FGV++I +H +K YD+A+L+L+ V Y PI LP
Sbjct: 61 --ILNQAEIAEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPISLPS 116
Query: 175 KGKSTCI 181
KG I
Sbjct: 117 KGDRNVI 123
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 88
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 89 LLVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 147
Query: 170 ICLPEK 175
+CLP++
Sbjct: 148 VCLPDR 153
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 88
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 89 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 147
Query: 170 ICLPEK 175
+CLP++
Sbjct: 148 VCLPDR 153
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 11/120 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+VGG++A G FPWQ + + CGGS+VN +VTA HCV + ++ V G++ I
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCV--ETGVKITVVAGEHNI 58
Query: 119 NSAVEPLPAYTFGVRK-INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEK 175
+T R I + P+ + ++Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 59 EET-----EHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADK 113
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 11/120 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+VGG++A G FPWQ + + CGGS+VN +VTA HCV + ++ V G++ I
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCV--ETGVKITVVAGEHNI 58
Query: 119 NSAVEPLPAYTFGVRK-INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEK 175
+T R I + P+ + ++Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 59 EET-----EHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADK 113
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 31 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 89
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 90 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 148
Query: 170 ICLPEK 175
+CLP++
Sbjct: 149 VCLPDR 154
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 88
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 89 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 147
Query: 170 ICLPEK 175
+CLP++
Sbjct: 148 VCLPDR 153
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 88
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 89 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 147
Query: 170 ICLPEK 175
+CLP++
Sbjct: 148 VCLPDR 153
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 90
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 91 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 149
Query: 170 ICLPEK 175
+CLP++
Sbjct: 150 VCLPDR 155
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 90
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 91 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 149
Query: 170 ICLPEK 175
+CLP++
Sbjct: 150 VCLPDR 155
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 64.3 bits (155), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 29 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 87
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 88 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 146
Query: 170 ICLPEK 175
+CLP++
Sbjct: 147 VCLPDR 152
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 63.9 bits (154), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 94
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 95 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 153
Query: 170 ICLPEK 175
+CLP++
Sbjct: 154 VCLPDR 159
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 63.9 bits (154), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 94
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 95 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 153
Query: 170 ICLPEK 175
+CLP++
Sbjct: 154 VCLPDR 159
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 63.9 bits (154), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 165 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 223
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 224 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 282
Query: 170 ICLPEK 175
+CLP++
Sbjct: 283 VCLPDR 288
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 63.9 bits (154), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 63/125 (50%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ AY + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 63.9 bits (154), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 107
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 108 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 166
Query: 170 ICLPEK 175
+CLP++
Sbjct: 167 VCLPDR 172
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 63.9 bits (154), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 11/126 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
RIV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTEND 59
Query: 116 YVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P
Sbjct: 60 LLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHP 118
Query: 170 ICLPEK 175
+CLP++
Sbjct: 119 VCLPDR 124
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 63.9 bits (154), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 7/126 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
IVGG + G +PWQ + S CGGS++ ++TA HC + ++
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ S + ++ FGV++I +H +K YD+A+L+L+ V Y PI LP K
Sbjct: 61 ILNQSEIAEDTSF-FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPISLPSK 117
Query: 176 GKSTCI 181
G I
Sbjct: 118 GDRNVI 123
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 63.2 bits (152), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQV-QVTLGDYV 117
I GG A G +PWQ I G CGGSLV+ V++A HC ++ +V LG +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
++S E T + I HP + + + D+A+L+L RP+ + +I PI LP
Sbjct: 61 LDSYSEDAKVSTL--KDIIPHP--SYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANA 116
Query: 178 S 178
S
Sbjct: 117 S 117
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 63.2 bits (152), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 38/116 (32%), Positives = 62/116 (53%), Gaps = 8/116 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG G PWQA + CGG++++ F+++TA HC+ + A++ +V +GD
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQ--AKRFKVRVGDR- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N+ E V + H +FT + +D+AVLRL P+ + ++AP LP
Sbjct: 58 -NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRMNVAPASLP 110
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 63.2 bits (152), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 42/131 (32%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y V KI+ VHP + + DR D+A+L+L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDR-DIALLKLKKPVPFSDYIHPV 118
Query: 171 CLPEKGKSTCI 181
CLP+K T +
Sbjct: 119 CLPDKQTVTSL 129
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 63.2 bits (152), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVAR-ASARQVQVTLGDYV 117
IVGG G PWQ + + G+ CGG+L+N VV+A HC + + R + LG++
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
++ R V + P +D+A+LRL +PV H+ P+CLPE+
Sbjct: 61 LSEH----DGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPER 114
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 63.2 bits (152), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 42/131 (32%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y V KI+ VHP + + DR D+A+L+L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDR-DIALLKLKKPVPFSDYIHPV 118
Query: 171 CLPEKGKSTCI 181
CLP+K T +
Sbjct: 119 CLPDKQTVTSL 129
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 63.2 bits (152), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 42/131 (32%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y V KI+ VHP + + DR D+A+L+L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDR-DIALLKLKKPVPFSDYIHPV 118
Query: 171 CLPEKGKSTCI 181
CLP+K T +
Sbjct: 119 CLPDKQTVTSL 129
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 63.2 bits (152), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 40/116 (34%), Positives = 60/116 (51%), Gaps = 6/116 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQV-QVTLGDYV 117
I GG A G +PWQ I G CGGSLV+ V++A HC ++ +V LG +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
++S E T + I HP + + + D+A+L+L RP+ + +I PI LP
Sbjct: 61 LDSYSEDAKVSTL--KDIIPHP--SYLQEGSQGDIALLQLSRPITFSRYIRPISLP 112
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 63.2 bits (152), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 40/116 (34%), Positives = 60/116 (51%), Gaps = 6/116 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQV-QVTLGDYV 117
I GG A G +PWQ I G CGGSLV+ V++A HC ++ +V LG +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
++S E T + I HP + + + D+A+L+L RP+ + +I PI LP
Sbjct: 61 LDSYSEDAKVSTL--KDIIPHP--SYLQEGSQGDIALLQLSRPITFSRYIRPISLP 112
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 63.2 bits (152), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 39/120 (32%), Positives = 63/120 (52%), Gaps = 11/120 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+VGG++A G FPWQ + + CGGS+VN +VTA HCV + ++ V G++ I
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCV--ETGVKITVVAGEHNI 58
Query: 119 NSAVEPLPAYTFGVRK-INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEK 175
+T R I + P+ + + Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 59 EET-----EHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADK 113
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEKGKSTCI 181
CLP++ + +
Sbjct: 119 CLPDRETAASL 129
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 42/118 (35%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVA--RASARQVQVTLGDY 116
IVGG E G +PWQA ++ GS RCG +L+N +V+A HC + AR + G
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYKNPARWT-ASFGVT 59
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ S ++ G+R+I VH +K P D YD+++ L PV Y + +CLP+
Sbjct: 60 IKPSKMKR------GLRRIIVHEKYKH-PSHD-YDISLAELSSPVPYTNAVHRVCLPD 109
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 45/136 (33%), Positives = 67/136 (49%), Gaps = 10/136 (7%)
Query: 47 CGVSVKNQGAQRRIVGGDEAGFGSFPWQ---AYIRIGSSR--CGGSLVNRFHVVTAGHCV 101
CG + R+VGG++A S+PWQ Y+R + R CGG+L+ HV+TA HC+
Sbjct: 1 CGAPIFQPNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCI 60
Query: 102 ARASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
++ +V LG + E Y GV I VH K+ R D+A+++L V
Sbjct: 61 --SNTLTYRVALGKNNLEVEDEAGSLYV-GVDTIFVHE--KWNSFLVRNDIALIKLAETV 115
Query: 162 QYMPHIAPICLPEKGK 177
+ I CLP +G
Sbjct: 116 ELGDTIQVACLPSEGS 131
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 45/117 (38%), Positives = 66/117 (56%), Gaps = 8/117 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG E S P+ A + R GS CGG LV+ V+TA HC+A+ A Q+++ LG + +
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMA-QLRLVLGLHTL 59
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+S P TF ++ HP +K P A D+A+L+LD V+ I P+ LP K
Sbjct: 60 DS-----PGLTFHIKAAIQHPRYKPVP-ALENDLALLQLDGKVKPSRTIRPLALPSK 110
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 16/129 (12%)
Query: 60 IVGGDEAGFGSFPWQ-----AYIRIGSSRCGGSLVNRFHVVTAGHCV-----ARASARQV 109
IVGG +A G FP+Q +I CG S+ N + +TAGHCV S Q+
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI 60
Query: 110 QVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 169
D +N E + V KI +H F + + D+++L+L + + ++AP
Sbjct: 61 VAGELDMSVNEGSEQI----ITVSKIILHENFDYNLLDN--DISLLKLSGSLTFNDNVAP 114
Query: 170 ICLPEKGKS 178
I LPE+G +
Sbjct: 115 IALPEQGHT 123
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEKGKSTCI 181
CLP++ + +
Sbjct: 119 CLPDRETAASL 129
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 61.2 bits (147), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 9/127 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVARASARQV-QVTLG 114
IVGG + +G +PWQ +++ + CGGSL+ V+TA HC + V ++ G
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
++ + P +++I +H +K + +D+A+++L P+ Y PI LP
Sbjct: 61 ILNLSDITKDTPFSQ--IKEIIIHQNYKVSE--GNHDIALIKLQAPLNYTEFQKPISLPS 116
Query: 175 KGKSTCI 181
KG ++ I
Sbjct: 117 KGDTSTI 123
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 61.2 bits (147), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 15/129 (11%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-------CGGSLVNRFHVVTAGHCVARASARQVQVT 112
IV G +A G PWQ + R CG SL++ V+TA HC+ + T
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDK-NFT 59
Query: 113 LGDYVINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPH 166
D ++ Y + KI+ +HP + + DR D+A+++L +PV + +
Sbjct: 60 ENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDY 118
Query: 167 IAPICLPEK 175
I P+CLP++
Sbjct: 119 IHPVCLPDR 127
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 60.8 bits (146), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 44/117 (37%), Positives = 66/117 (56%), Gaps = 8/117 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG E S P+ A + R GS CGG LV+ V+TA HC+A+ A Q+++ LG + +
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMA-QLRLVLGLHTL 59
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+S P TF ++ HP +K P A ++A+L+LD V+ I P+ LP K
Sbjct: 60 DS-----PGLTFHIKAAIQHPRYKPVP-ALENNLALLQLDGKVKPSRTIRPLALPSK 110
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 60.8 bits (146), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 38/121 (31%), Positives = 58/121 (47%), Gaps = 15/121 (12%)
Query: 59 RIVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
RIV G+EA GS+PWQ + + G CGGSL+N VVTA HC S V G++
Sbjct: 15 RIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV---VVAGEF 71
Query: 117 VINSAVEPLPAYTFGVRKINVHPYF---KFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
S+ E ++K+ + F K+ D+ +L+L + ++ +CLP
Sbjct: 72 DQGSSSEK-------IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLP 124
Query: 174 E 174
Sbjct: 125 S 125
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 60.1 bits (144), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 6/121 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-CGGSLVNRFHVVTAGHCV--ARASARQVQVTLGDY 116
IVGG ++ G++PW + + CG SLV+R +V+A HCV + + LG +
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKWKAVLGLH 60
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 176
+ ++ P T + +I ++P++ + D+A++ L+ V Y +I PICLPE+
Sbjct: 61 MASNLTSP-QIETRLIDQIVINPHY--NKRRKNNDIAMMHLEMKVNYTDYIQPICLPEEN 117
Query: 177 K 177
+
Sbjct: 118 Q 118
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 60.1 bits (144), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + T D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDK-NFTENDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR ++A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-NIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 60.1 bits (144), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IV G +A G PWQ + S + CG SL++ V+TA HC+ + + D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIE-NDL 59
Query: 117 VINSAVEPLPAYTFGVRKIN------VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ Y + KI+ +HP + + DR D+A+++L +PV + +I P+
Sbjct: 60 LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPV 118
Query: 171 CLPEK 175
CLP++
Sbjct: 119 CLPDR 123
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 59.7 bits (143), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 9/126 (7%)
Query: 59 RIVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
RIVGG + G +PWQ +R G+ CGGSL++ V+TA HC R ++
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPE---RNRVLSRWRVF 173
Query: 118 INSAVEPLP-AYTFGVRKINVH----PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICL 172
+ + P GV+ + H P+ + + D+A++ L P+ +I P+CL
Sbjct: 174 AGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCL 233
Query: 173 PEKGKS 178
P G++
Sbjct: 234 PAAGQA 239
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 59.7 bits (143), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 9/126 (7%)
Query: 59 RIVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
RIVGG + G +PWQ +R G+ CGGSL++ V+TA HC R ++
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPE---RNRVLSRWRVF 173
Query: 118 INSAVEPLP-AYTFGVRKINVH----PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICL 172
+ + P GV+ + H P+ + + D+A++ L P+ +I P+CL
Sbjct: 174 AGAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCL 233
Query: 173 PEKGKS 178
P G++
Sbjct: 234 PAAGQA 239
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 46/136 (33%), Positives = 70/136 (51%), Gaps = 20/136 (14%)
Query: 60 IVGGDEAGFGSFPWQ---AYIRIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
+VGG++A S+PWQ Y++ + R CGG+L+ V+TA HC+ ++ R +V +G
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCI--SNTRTYRVAVG 58
Query: 115 DYVINSAVEPLPAYTF-GVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N VE F GV I+VH ++ R D+A+++L V+ I CLP
Sbjct: 59 KN--NLEVEDEEGSLFVGVDTIHVHK--RWNALLLRNDIALIKLAEHVELSDTIQVACLP 114
Query: 174 EKGKSTCIPISNLLPK 189
EK +LLPK
Sbjct: 115 EK--------DSLLPK 122
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 42/124 (33%), Positives = 62/124 (50%), Gaps = 12/124 (9%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ I
Sbjct: 22 KIVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 77
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKS 178
N +E + KI HP F + D+ +++L PV+ H+A + LP S
Sbjct: 78 N-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAHVATVALP----S 129
Query: 179 TCIP 182
+C P
Sbjct: 130 SCAP 133
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 57/120 (47%), Gaps = 15/120 (12%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IV G+EA GS+PWQ + + G CGGSL+N VVTA HC S V G++
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV---VVAGEFD 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYF---KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
S+ E ++K+ + F K+ D+ +L+L + ++ +CLP
Sbjct: 58 QGSSSEK-------IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPS 110
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 58.2 bits (139), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IV G+EA GS+PWQ + + G CGGSL+N VVTA HC S V G++
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSDV---VVAGEFD 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYF---KFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
S+ E ++K+ + F K+ D+ +L+L + ++ +CLP
Sbjct: 58 QGSSSEK-------IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLP 109
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 57.4 bits (137), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 44 DPRCGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCV-- 101
+P CG+S + G RI GG +A G FPWQ I +G + G+L+ V+TA H V
Sbjct: 73 EPVCGLSARTTGG--RIYGGQKAKPGDFPWQVLI-LGGTTAAGALLYDNWVLTAAHAVYE 129
Query: 102 ARASARQVQVTLGDYVINSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRLDRP 160
+ A + + +G S P YT + + +H + D D+A+++L+
Sbjct: 130 QKHDASALDIRMGTLKRLS-----PHYTQAWSEAVFIHEGYTHDAGFDN-DIALIKLNNK 183
Query: 161 VQYMPHIAPICLPEK 175
V +I PICLP K
Sbjct: 184 VVINSNITPICLPRK 198
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 57.4 bits (137), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 44 DPRCGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCV-- 101
+P CG+S + G Q I GG +A G FPWQ I +G + G+L+ V+TA H V
Sbjct: 148 EPVCGLSARTTGGQ--IYGGQKAKPGDFPWQVLI-LGGTTAAGALLYDNWVLTAAHAVYE 204
Query: 102 ARASARQVQVTLGDYVINSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRLDRP 160
+ A + + +G S P YT + + +H + D D+A+++L+
Sbjct: 205 QKHDASALDIRMGTLKRLS-----PHYTQAWSEAVFIHEGYTHDAGFDN-DIALIKLNNK 258
Query: 161 VQYMPHIAPICLPEK 175
V +I PICLP K
Sbjct: 259 VVINSNITPICLPRK 273
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 57.4 bits (137), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 10/121 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSS---RCGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
+VGGDE P+ + +S C G+L+NR V+TA HC R +++ LG +
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHC----DRRNIRIKLGMH 56
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 176
N E + ++ F P D+ ++RL RPV Y HIAP+ LP +
Sbjct: 57 SKNIRNEDEQIRVPRGKYFCLNTKF---PNGLDKDIMLIRLRRPVTYSTHIAPVSLPSRS 113
Query: 177 K 177
+
Sbjct: 114 R 114
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 57.0 bits (136), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 9/125 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG + G +PWQ +R G+ CGGSL++ V+TA HC R ++
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPE---RNRVLSRWRVFA 57
Query: 119 NSAVEPLP-AYTFGVRKINVH----PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ + P GV+ + H P+ + + D+A++ L P+ +I P+CLP
Sbjct: 58 GAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLP 117
Query: 174 EKGKS 178
G++
Sbjct: 118 AAGQA 122
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 57.0 bits (136), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 41/119 (34%), Positives = 60/119 (50%), Gaps = 9/119 (7%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSS---RCGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
+VGG A S+PWQ + + GSS CGGSL+ + V+TA HCV SAR +V LG
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCV--DSARTWRVVLG 58
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
++ +N+ T V + +H + A YD+A+LRL+ + LP
Sbjct: 59 EHNLNTNEGKEQIMT--VNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAALP 115
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 56.6 bits (135), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 17/127 (13%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVA----RASARQVQV 111
IVGG EA +PWQ +R+ CGGSL++ V+TA HCV +A +VQ+
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQL 60
Query: 112 TLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPIC 171
+ P V +I VHP F +T Q D+A+L L+ PV+ H+ +
Sbjct: 61 REQHLYYQDQLLP-------VSRIIVHPQF-YTAQIGA-DIALLELEEPVKVSSHVHTVT 111
Query: 172 LPEKGKS 178
LP ++
Sbjct: 112 LPPASET 118
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 56.6 bits (135), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 17/127 (13%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVA----RASARQVQV 111
IVGG EA +PWQ +R+ CGGSL++ V+TA HCV +A +VQ+
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQL 60
Query: 112 TLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPIC 171
+ P V +I VHP F +T Q D+A+L L+ PV+ H+ +
Sbjct: 61 REQHLYYQDQLLP-------VSRIIVHPQF-YTAQIGA-DIALLELEEPVKVSSHVHTVT 111
Query: 172 LPEKGKS 178
LP ++
Sbjct: 112 LPPASET 118
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 56.6 bits (135), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 17/127 (13%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVA----RASARQVQV 111
IVGG EA +PWQ +R+ CGGSL++ V+TA HCV +A +VQ+
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQL 60
Query: 112 TLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPIC 171
+ P V +I VHP F +T Q D+A+L L+ PV+ H+ +
Sbjct: 61 REQHLYYQDQLLP-------VSRIIVHPQF-YTAQIGA-DIALLELEEPVKVSSHVHTVT 111
Query: 172 LPEKGKS 178
LP ++
Sbjct: 112 LPPASET 118
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 56.6 bits (135), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 7/118 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
IVGG EA FPWQ +R SS CGGS++N VV A HC+ + V + +G++
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAPALVSLVVGEH 60
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+S+ T V I V+ + P DV+V++ + + ++ PIC P+
Sbjct: 61 --DSSAASTVRQTHDVDSIFVNE--NYDPATLENDVSVIKTAVAITFDINVGPICAPD 114
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 56.2 bits (134), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 8/115 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG S P+Q + GS CGGSL+N VV+A HC ++QV LG++ I
Sbjct: 8 KIVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCY----KSRIQVRLGEHNI 63
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +E + KI HP F + D+ +++L P +A + LP
Sbjct: 64 D-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSRVATVSLP 114
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 55.8 bits (133), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 15/127 (11%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-------CGGSLVNRFHVVTAGHCV-ARASARQVQV 111
I+GG +A G++PW ++I + CGGSL+N ++TA HC + ++
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 112 TLG----DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 167
G ++ N V+P P V KI +H K++ ++ D+A++++ PV I
Sbjct: 61 IFGAKEVEWGTNKPVKP-PLQERYVEKIIIHE--KYSASSEANDIALMKITPPVTCGHFI 117
Query: 168 APICLPE 174
P CLP+
Sbjct: 118 GPGCLPQ 124
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 55.8 bits (133), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + GS CGGSL+N VV+A HC ++QV LG++ I+
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCY----KSRIQVRLGEHNID 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + KI HP F + D+ +++L P +A + LP
Sbjct: 57 -VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSRVATVSLP 106
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 55.8 bits (133), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 12/124 (9%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ I
Sbjct: 10 KIVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNI 65
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKS 178
N +E + KI HP F + D+ +++L PV+ +A + LP S
Sbjct: 66 N-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----S 117
Query: 179 TCIP 182
+C P
Sbjct: 118 SCAP 121
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 13/124 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIR-IGSSR-CGGSLVNRFHVVTAGHCVAR------ASARQVQV 111
+VGG +A G +PWQ + +G CG SL++ +V+A HC + Q
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 112 TLGDYVINSAVEPLPAYTFGVRKINVHPYFK-FTPQADRYDVAVLRLDRPVQYMPHIAPI 170
LG + + P +++I HP+F FT YD+A+L L++P +Y + PI
Sbjct: 61 FLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFD---YDIALLELEKPAEYSSMVRPI 116
Query: 171 CLPE 174
CLP+
Sbjct: 117 CLPD 120
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 63 GDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINS 120
G++A GS+PWQ + + G CGGSL++ VVTA HC + S V G++ S
Sbjct: 1 GEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDV---VVAGEFDQGS 57
Query: 121 AVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
E + + ++ +P KF R D+ +L+L P Q+ ++ +CLP
Sbjct: 58 DEENIQV--LKIAQVFKNP--KFNMFTVRNDITLLKLATPAQFSETVSAVCLP 106
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + GS CGGSL+N VV+A HC ++QV LG++ I+
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCY----KSRIQVRLGEHNID 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + KI HP F + D+ +++L P +A + LP
Sbjct: 57 -VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLXSRVATVSLP 106
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 13/124 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIR-IGSSR-CGGSLVNRFHVVTAGHCVAR------ASARQVQV 111
+VGG +A G +PWQ + +G CG SL++ +V+A HC + Q
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 112 TLGDYVINSAVEPLPAYTFGVRKINVHPYFK-FTPQADRYDVAVLRLDRPVQYMPHIAPI 170
LG + + P +++I HP+F FT YD+A+L L++P +Y + PI
Sbjct: 61 FLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFD---YDIALLELEKPAEYSSMVRPI 116
Query: 171 CLPE 174
CLP+
Sbjct: 117 CLPD 120
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 36/119 (30%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
++GGDE + A + S CGG+L+N+ V+TA HC R + R V+N
Sbjct: 1 VIGGDECNINEHRFLALVYANGSLCGGTLINQEWVLTARHC-DRGNMRIYLGMHNLKVLN 59
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRY---DVAVLRLDRPVQYMPHIAPICLPEK 175
+R+ YF + D D+ ++RL+RPV+ HIAP+ LP
Sbjct: 60 KDA---------LRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPSN 109
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 8/116 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + GS CGGSL+N VV+A HC ++QV LG++ I+
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCY----KSRIQVRLGEHNID 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+E + KI HP F + D+ +++L P +A + LP
Sbjct: 57 -VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSRVATVSLPRS 108
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 42/123 (34%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A I LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATIALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + GS CGGSL+N VV+A HC ++QV LG++ I+
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCY----KSRIQVRLGEHNID 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + KI HP F + D+ +++L P +A + LP
Sbjct: 57 -VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSRVATVSLP 106
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 9/116 (7%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IV G++A GS+PWQ + + G CGGSL++ VVTA HC + S V G++
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSDV---VVAGEFD 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
S E + + ++ +P KF R D+ +L+L P Q+ ++ + LP
Sbjct: 58 QGSDEENIQV--LKIAQVFKNP--KFNMFTVRNDITLLKLATPAQFSETVSAVSLP 109
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRETYNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 55.1 bits (131), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRETYNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + GS CGGSL+N VV+A HC ++QV LG++ I+
Sbjct: 1 IVGGYTCAANSVPYQVSLNSGSHFCGGSLINSQWVVSAAHCY----KSRIQVRLGEHNID 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + KI HP F + D+ +++L P +A + LP
Sbjct: 57 -VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSRVATVSLP 106
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHPNFDH--KTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 39/121 (32%), Positives = 60/121 (49%), Gaps = 13/121 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-----GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG EA S P+ AY++I GS +CGG L+ V+TA HC S ++QVTLG
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHC----SGSKIQVTLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ I + V KI HP + ++ D+ +L+L + + P+ LP
Sbjct: 57 AHNIKE--QEKMQQIIPVVKIIPHPAYNSKTISN--DIMLLKLKSKAKRSSAVKPLNLPR 112
Query: 175 K 175
+
Sbjct: 113 R 113
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 54.7 bits (130), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 11 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 66
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + D+ +++L PV+ +A + LP S+
Sbjct: 67 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SS 118
Query: 180 CIP 182
C P
Sbjct: 119 CAP 121
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 54.3 bits (129), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 9/115 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCV-ARASARQVQVTLGDYV 117
IVGG +A G +P+Q +R+ GS RCG S+++ +V+TA HCV ++ +++V +G
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHRCGASILDNNNVLTAAHCVDGLSNLNRLKVHVG--- 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICL 172
N E Y +N + Y F R DVA++ L P+++ + PI L
Sbjct: 58 TNYLSESGDVYDVEDAVVNKN-YDDFLL---RNDVALVHLTNPIKFNDLVQPIKL 108
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 54.3 bits (129), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ I
Sbjct: 5 KIVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N VE + + I VHP + D+ +++L +A I LP
Sbjct: 61 N-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 111
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 54.3 bits (129), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ I
Sbjct: 6 KIVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 61
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N VE + + I VHP + D+ +++L +A I LP
Sbjct: 62 N-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 112
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 53.9 bits (128), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLXSRVASISLP 106
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 53.9 bits (128), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ I
Sbjct: 14 KIVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 69
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N VE + + I VHP + D+ +++L +A I LP
Sbjct: 70 N-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 120
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 53.9 bits (128), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 53.9 bits (128), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 62/127 (48%), Gaps = 13/127 (10%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSS-----RCGGSLVNRFHVVTAGHCVARASARQVQVTL 113
R+V G++A S+ WQ ++ CGGSL+ VVTAGHC+ +++R QV L
Sbjct: 11 RVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCI--STSRTYQVVL 68
Query: 114 GDY---VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
G+Y V+ + + +P + VHP + A D+A+++L R Q +
Sbjct: 69 GEYDRSVLQGSEQVIP---INAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLA 125
Query: 171 CLPEKGK 177
LP G
Sbjct: 126 NLPPAGD 132
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 53.9 bits (128), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ I
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 75
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N VE + + I VHP + D+ +++L +A I LP
Sbjct: 76 N-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 126
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 8/115 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ I
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNI 75
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N VE + + I VHP + D+ +++L +A I LP
Sbjct: 76 N-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 126
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 53.5 bits (127), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 53.5 bits (127), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 53.5 bits (127), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 8/119 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
++ G G PWQ + + CG L++ V+TA HC+ + +++ V LG+Y
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDES--KKLLVRLGEYD 58
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 176
+ + ++++ VHP ++ D+A+L L +P I PICLP+ G
Sbjct: 59 LRRWEKW--ELDLDIKEVFVHP--NYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSG 113
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 53.5 bits (127), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 53.5 bits (127), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCXKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 53.5 bits (127), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 8/113 (7%)
Query: 61 VGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINS 120
VGG S P+Q + GS CGGSL+N VV+A HC ++QV LG++ I+
Sbjct: 2 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCY----KSRIQVRLGEHNID- 56
Query: 121 AVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + KI HP F + D+ +++L P +A + LP
Sbjct: 57 VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSRVATVSLP 106
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 53.5 bits (127), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNKRRKNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 53.5 bits (127), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 53.5 bits (127), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 53.5 bits (127), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLXSRVASISLP 106
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 53.5 bits (127), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 8/119 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
++ G G PWQ + + CG L++ V+TA HC+ + +++ V LG+Y
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDES--KKLLVRLGEYD 58
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 176
+ + ++++ VHP ++ D+A+L L +P I PICLP+ G
Sbjct: 59 LRRWEKW--ELDLDIKEVFVHP--NYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSG 113
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 53.5 bits (127), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 53.1 bits (126), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 53.1 bits (126), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 53.1 bits (126), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 7/116 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
++GGDE P+ A++ CG +L+N+ VVTA HC + Q+ LG V +
Sbjct: 1 VLGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVVTAAHC----DSTNFQMQLG--VHS 54
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
V T ++ + P + D+ D+ +++LD+P+ HIAP+ LP
Sbjct: 55 KKVLNEDEQTRNPKEKFICPNKNMSEVLDK-DIMLIKLDKPISNSKHIAPLSLPSN 109
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 53.1 bits (126), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 53.1 bits (126), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 53.1 bits (126), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 53.1 bits (126), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 53.1 bits (126), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLLNSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 53.1 bits (126), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 40/123 (32%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
+E + KI HP F + ++ +++L PV+ +A + LP S+
Sbjct: 57 -VLEGNEQFV-NAAKIIKHP--NFDRKTLNNNIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 12/123 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
V KI HP F + ++ +++L PV+ +A + LP S+
Sbjct: 57 --VLEGDEQFVNAAKIIKHP--NFDRKTLNNNIMLIKLSSPVKLNARVATVALP----SS 108
Query: 180 CIP 182
C P
Sbjct: 109 CAP 111
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 16 RVVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 75
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 76 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 123
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A + LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASVSLP 106
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 52.4 bits (124), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 19 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 78
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 79 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 126
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 18 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 77
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 78 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 125
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 77 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 124
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 620
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 621 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 668
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 80 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 127
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 80 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 127
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/118 (33%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 59 RIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGD 115
R+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ +EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 77 HQ-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 124
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
I+GG EA S P+ AY+ I RCGG L+ V+TA HC + + VTLG
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWGSS----INVTLGA 56
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ I EP + R I P+ + P+ D+ +L+L+R + + P+ LP
Sbjct: 57 HNIKEQ-EPTQQFIPVKRPI---PHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLP 110
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S +QA ++ G CGGSL++ VV+A HC ++QV LG++ N
Sbjct: 1 IVGGYECRKNSASYQASLQSGYHFCGGSLISSTWVVSAAHCY----KSRIQVRLGEH--N 54
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
AV K+ +HP + + D+ +++L +P +++ + LP S+
Sbjct: 55 IAVNEGTEQFIDSVKVIMHP--SYNSRNLDNDIMLIKLSKPASLNSYVSTVALPSSCASS 112
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 38/124 (30%), Positives = 61/124 (49%), Gaps = 13/124 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIR-IGSSR-CGGSLVNRFHVVTAGHCVAR------ASARQVQV 111
+VGG +A G +PWQ + +G CG SL++ +V+A HC + Q
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 112 TLGDYVINSAVEPLPAYTFGVRKINVHPYFK-FTPQADRYDVAVLRLDRPVQYMPHIAPI 170
LG + + P +++I HP+F FT YD+A+L L++P +Y + PI
Sbjct: 61 FLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFD---YDIALLELEKPAEYSSMVRPI 116
Query: 171 CLPE 174
LP+
Sbjct: 117 SLPD 120
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS----SRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
I+GG EA S P+ AY+ I RCGG L+ V+TA HC + + VTLG
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGSS----INVTLGA 56
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ I EP + R I P+ + P+ D+ +L+L+R + + P+ LP
Sbjct: 57 HNIKEQ-EPTQQFIPVKRPI---PHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLP 110
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 58/125 (46%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVAR--ASARQVQVTL 113
IVGG EA +PWQ +R+ CGGSL++ V+TA HCV ++V L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRVQL 60
Query: 114 GDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ + + LP V +I VHP F D+A+L L+ PV + + LP
Sbjct: 61 REQHLYYQDQLLP-----VSRIIVHPQFYIIQTG--ADIALLELEEPVNISSRVHTVMLP 113
Query: 174 EKGKS 178
++
Sbjct: 114 PASET 118
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 58/125 (46%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVAR--ASARQVQVTL 113
IVGG EA +PWQ +R+ CGGSL++ V+TA HCV ++V L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLRVQL 60
Query: 114 GDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ + + LP V +I VHP F D+A+L L+ PV + + LP
Sbjct: 61 REQHLYYQDQLLP-----VSRIIVHPQFYIIQTG--ADIALLELEEPVNISSRVHTVMLP 113
Query: 174 EKGKS 178
++
Sbjct: 114 PASET 118
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/121 (32%), Positives = 58/121 (47%), Gaps = 12/121 (9%)
Query: 62 GGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSA 121
GG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN-V 65
Query: 122 VEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKSTCI 181
+E + KI HP F + D+ +++L PV+ +A + LP S+C
Sbjct: 66 LEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SSCA 118
Query: 182 P 182
P
Sbjct: 119 P 119
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/121 (32%), Positives = 58/121 (47%), Gaps = 12/121 (9%)
Query: 62 GGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSA 121
GG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN-V 65
Query: 122 VEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKSTCI 181
+E + KI HP F + D+ +++L PV+ +A + LP S+C
Sbjct: 66 LEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SSCA 118
Query: 182 P 182
P
Sbjct: 119 P 119
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/121 (32%), Positives = 58/121 (47%), Gaps = 12/121 (9%)
Query: 62 GGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSA 121
GG S P+Q + G CGGSL+N VV+A HC ++QV LG++ IN
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHFCGGSLINDQWVVSAAHCY----KSRIQVRLGEHNIN-V 65
Query: 122 VEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKSTCI 181
+E + KI HP F + D+ +++L PV+ +A + LP S+C
Sbjct: 66 LEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNARVATVALP----SSCA 118
Query: 182 P 182
P
Sbjct: 119 P 119
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 36/113 (31%), Positives = 51/113 (45%), Gaps = 8/113 (7%)
Query: 61 VGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINS 120
VGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN- 56
Query: 121 AVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVASISLP 106
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 51.2 bits (121), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S P Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KTRVEVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
E + R I HP ++ D+ +++L +P ++ P+ LP S+
Sbjct: 56 KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----SS 108
Query: 180 CIPISNL 186
C P +
Sbjct: 109 CAPAGTM 115
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 51.2 bits (121), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S P Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
E + R I HP ++ D+ +++L +P ++ P+ LP S+
Sbjct: 56 KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----SS 108
Query: 180 CIPISNL 186
C P +
Sbjct: 109 CAPAGTM 115
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 50.8 bits (120), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 58/125 (46%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVAR--ASARQVQVTL 113
IVGG EA +PWQ +R+ CGGSL++ V+TA HC+ ++V L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKDLATLRVQL 60
Query: 114 GDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ + + LP V +I VHP F D+A+L L+ PV + + LP
Sbjct: 61 REQHLYYQDQLLP-----VSRIIVHPQFYIIQTG--ADIALLELEEPVNISSRVHTVMLP 113
Query: 174 EKGKS 178
++
Sbjct: 114 PASET 118
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 35/121 (28%), Positives = 63/121 (52%), Gaps = 6/121 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQVQVT--LGDY 116
IVGG +A G++PW + CG SLV+ +V+A HCV + + T LG +
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLH 60
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 176
+ ++ P + +I ++P++ + + D+A++ L+ V Y +I PI LPE+
Sbjct: 61 MKSNLTSPQTVPRL-IDEIVINPHYNRRRKDN--DIAMMHLEFKVNYTDYIQPISLPEEN 117
Query: 177 K 177
+
Sbjct: 118 Q 118
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRI-----GSSRCGGSLVNRFHVVTAGHC-VARASARQVQVTLGDYVINSAVEPL 125
PWQA I + G C G++V+ + V+TA HC ++V++G + +E +
Sbjct: 460 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVV 519
Query: 126 ---PAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
P Y +K P F YDVA+++L ++Y I PICLP
Sbjct: 520 LFHPNYNINGKKEAGIPEFY------DYDVALIKLKNKLKYGQTIRPICLP 564
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRI-----GSSRCGGSLVNRFHVVTAGHC-VARASARQVQVTLGDYVINSAVEPL 125
PWQA I + G C G++V+ + V+TA HC ++V++G + +E +
Sbjct: 469 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVV 528
Query: 126 ---PAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
P Y +K P F YDVA+++L ++Y I PICLP
Sbjct: 529 LFHPNYNINGKKEAGIPEFY------DYDVALIKLKNKLKYGQTIRPICLP 573
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRI-----GSSRCGGSLVNRFHVVTAGHC-VARASARQVQVTLGDYVINSAVEPL 125
PWQA I + G C G++V+ + V+TA HC ++V++G + +E +
Sbjct: 479 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVV 538
Query: 126 ---PAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
P Y +K P F YDVA+++L ++Y I PICLP
Sbjct: 539 LFHPNYNINGKKEAGIPEFY------DYDVALIKLKNKLKYGQTIRPICLP 583
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 50.4 bits (119), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRI-----GSSRCGGSLVNRFHVVTAGHC-VARASARQVQVTLGDYVINSAVEPL 125
PWQA I + G C G++V+ + V+TA HC ++V++G + +E +
Sbjct: 235 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVV 294
Query: 126 ---PAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
P Y +K P F YDVA+++L ++Y I PICLP
Sbjct: 295 LFHPNYNINGKKEAGIPEFY------DYDVALIKLKNKLKYGQTIRPICLP 339
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRI-----GSSRCGGSLVNRFHVVTAGHC-VARASARQVQVTLGDYVINSAVEPL 125
PWQA I + G C G++V+ + V+TA HC ++V++G + +E +
Sbjct: 227 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVV 286
Query: 126 ---PAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
P Y +K P F YDVA+++L ++Y I PICLP
Sbjct: 287 LFHPNYNINGKKEAGIPEFY------DYDVALIKLKNKLKYGQTIRPICLP 331
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRI-----GSSRCGGSLVNRFHVVTAGHC-VARASARQVQVTLGDYVINSAVEPL 125
PWQA I + G C G++V+ + V+TA HC ++V++G + +E +
Sbjct: 28 PWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVV 87
Query: 126 ---PAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
P Y +K P F YDVA+++L ++Y I PICLP
Sbjct: 88 LFHPNYNINGKKEAGIPEFY------DYDVALIKLKNKLKYGQTIRPICLP 132
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S P Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
E + R I HP ++ D+ +++L +P ++ P+ LP ++
Sbjct: 56 KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----TS 108
Query: 180 CIPISNL 186
C P +
Sbjct: 109 CAPAGTM 115
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG E S P Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 20 KIVGGYECKPYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI 75
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKS 178
E + R I HP ++ D+ +++L +P ++ P+ LP +
Sbjct: 76 K-VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----T 127
Query: 179 TCIPISNL 186
+C P +
Sbjct: 128 SCAPAGTM 135
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 50.1 bits (118), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 40/146 (27%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 45 PRCGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVA 102
P CG+ ++ +I G A G+ PW A + G CGGSL+ +VTA HC+
Sbjct: 141 PVCGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLH 200
Query: 103 RA--------------SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQAD 148
++ S ++ LG + + E GV+ +HP ++ P
Sbjct: 201 QSLDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDE--NEQHLGVKHTTLHP--QYDPNTF 256
Query: 149 RYDVAVLRLDRPVQYMPHIAPICLPE 174
DVA++ L + PICLPE
Sbjct: 257 ENDVALVELLESPVLNAFVMPICLPE 282
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 50.1 bits (118), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRI----GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
I+GG EA S P+ A+++ RCGG LV + V+TA HC + VTLG
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLGA 56
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ I E + R I P+ + P+ D+ +L+L+R ++ + P+ LP
Sbjct: 57 HNIKEQ-ERTQQFIPVKRPI---PHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLP 110
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 50.1 bits (118), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+AGHC ++QV LG++ I
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCY----KSRIQVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + KI HP ++ + D+ +++L H++ I LP
Sbjct: 56 EVLEGNEQF-INAAKIIRHP--QYDRKTLNNDIMLIKLSSRAVINAHVSTISLP 106
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 50.1 bits (118), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 58/117 (49%), Gaps = 13/117 (11%)
Query: 60 IVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA-SARQVQVTLGDY 116
+VGG A S+PWQ +R G CGG+L++ V+TA HC+ ++ +V LG +
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAH 77
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+EP V++I V F + R D+A+L+L P + P CLP
Sbjct: 78 Q-EVNLEP------HVQEIEVSRLFL---EPTRKDIALLKLSSPAVITDKVIPACLP 124
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 49.7 bits (117), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 61/114 (53%), Gaps = 7/114 (6%)
Query: 59 RIVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
RI+GG EA + P+ A +++ G+ CGG LV V++A HC+ A+ +VQV LG +
Sbjct: 7 RILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHS 66
Query: 118 INSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ +P P+ + V + HP + P +D+ +L+L P + P+
Sbjct: 67 LS---QPEPSKRLYDVLRAVPHPDSQ--PDTIDHDLLLLQLSEKATLGPAVRPL 115
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRI----GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
IVGG EA S P+ A +++ GS CGG+L++ V+TA HC+ R V V LG
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVNVVLGA 60
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ + + EP + F V ++ ++ Y + D+ +++L P +A + LP++
Sbjct: 61 HNVRTQ-EPTQQH-FSVAQVFLNNY---DAENKLNDILLIQLSSPANLSASVATVQLPQQ 115
Query: 176 GK 177
+
Sbjct: 116 DQ 117
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/127 (31%), Positives = 58/127 (45%), Gaps = 12/127 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S P Q + G CGGSLVN VV+A HC +V V LG++ I
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVAVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
E + R I HP ++ D+ +++L +P ++ P+ LP S+
Sbjct: 56 KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----SS 108
Query: 180 CIPISNL 186
C P +
Sbjct: 109 CAPAGTM 115
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + GS CGGSL++ VV+A HC ++QV LG++ I
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHFCGGSLISEQWVVSAAHCY----KTRIQVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + V+ I HP K+ D+ +++L P ++ I LP
Sbjct: 56 KVLEGNEQFINAVKIIR-HP--KYNRDTLDNDIMLIKLSSPAVINARVSTISLP 106
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 59/123 (47%), Gaps = 13/123 (10%)
Query: 63 GDEAGFGSFPWQAYIRIGSS-----RCGGSLVNRFHVVTAGHCVARASARQVQVTLGDY- 116
G++A S+ WQ ++ CGGSL+ VVTAGHC+ +++R QV LG+Y
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCI--STSRTYQVVLGEYD 59
Query: 117 --VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
V+ + + +P + VHP + A D+A+++L R Q + LP
Sbjct: 60 RSVLEGSEQVIP---INAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLPP 116
Query: 175 KGK 177
G
Sbjct: 117 AGD 119
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG EA + P+ A +++ G+ CGG LV V++A HC+ A+ +VQV LG + +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
S EP +R + P+ + P +D+ +L+L P + P+
Sbjct: 61 -SQPEPSKRLYDVLRAV---PHPDYQPDTIDHDLLLLQLSEKATLGPAVRPL 108
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 49.3 bits (116), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/119 (31%), Positives = 52/119 (43%), Gaps = 10/119 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG A G FP+ I R G CGGSL+N V+TA HCV+ + Q+ G
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S T + + VHP + + D+A+L+L + +I L G
Sbjct: 61 TSG-----GITSSLSSVRVHPSYS----GNNNDLAILKLSTSIPSGGNIGYARLAASGS 110
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 49.3 bits (116), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/119 (31%), Positives = 52/119 (43%), Gaps = 10/119 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG A G FP+ I R G CGGSL+N V+TA HCV+ + Q+ G
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S T + + VHP + + D+A+L+L + +I L G
Sbjct: 61 TSG-----GITSSLSSVRVHPSYS----GNNNDLAILKLSTSIPSGGNIGYARLAASGS 110
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 49.3 bits (116), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S P Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 1 IVGGYECKPYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
E + R I HP ++ D+ +++L +P ++ P+ LP ++
Sbjct: 56 KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----TS 108
Query: 180 CIPISNL 186
C P +
Sbjct: 109 CAPAGTM 115
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 49.3 bits (116), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 12/134 (8%)
Query: 47 CGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSS-RCGGSLVNRFHVVTAGHCV--AR 103
CGV + ++RIVGG A G PWQ I+ S CGG + ++TA HC+ ++
Sbjct: 309 CGVKNRMHIRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCLRASK 368
Query: 104 ASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ- 162
Q+ T+ D++ + Y V +I H + + D+A++ + +
Sbjct: 369 THRYQIWTTVVDWIHPDLKRIVIEY---VDRIIFHE--NYNAGTYQNDIALIEMKKDGNK 423
Query: 163 ---YMPHIAPICLP 173
+P P C+P
Sbjct: 424 KDCELPRSIPACVP 437
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 47/141 (33%), Positives = 63/141 (44%), Gaps = 19/141 (13%)
Query: 47 CGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSSR-------CGGSLVNRFHVVTAGH 99
CG+ K + Q GG S PWQA I + R CGG L++ V+TA H
Sbjct: 2 CGLR-KYKEPQLHSTGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAH 60
Query: 100 CVARASA-RQVQVTLG-DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
C + Q++V LG Y + E TF V+K VH +F D+A+L+L
Sbjct: 61 CFQESYLPDQLKVVLGRTYRVKPGEE---EQTFKVKKYIVHK--EFDDDTYNNDIALLQL 115
Query: 158 --DRP--VQYMPHIAPICLPE 174
D P Q + ICLPE
Sbjct: 116 KSDSPQCAQESDSVRAICLPE 136
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + GS CGGSL++ VV+A HC ++QV LG++ N
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHFCGGSLISEQWVVSAAHCY----KTRIQVRLGEH--N 54
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
V KI HP K+ D+ +++L P ++ I LP
Sbjct: 55 IKVLEGNEQFINAAKIIRHP--KYNRDTLDNDIMLIKLSSPAVINARVSTISLP 106
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 52/115 (45%), Gaps = 9/115 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG G + P+Q + G CGGSL+N VV+A HC +QV LG+ IN
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSG----IQVRLGEDNIN 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM-PHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 -VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLXDSRVASISLP 107
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 51/113 (45%), Gaps = 8/113 (7%)
Query: 61 VGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINS 120
VGG G + P+Q + G CGGSL++ VV+A HC +QV LG+ IN
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHFCGGSLIDSQWVVSAAHCYKSG----IQVRLGEDNIN- 56
Query: 121 AVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
VE + + I VHP + D+ +++L +A I LP
Sbjct: 57 VVEGNEQFISASKSI-VHP--SYDSNTLNNDIMLIKLKSAASLDSRVASISLP 106
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 12/128 (9%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+IVGG E S Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 15 KIVGGYECKAYSQAHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI 70
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKS 178
E + R I HP ++ D+ +++L +P ++ P+ LP +
Sbjct: 71 -KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----T 122
Query: 179 TCIPISNL 186
+C P +
Sbjct: 123 SCAPAGTM 130
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 39/127 (30%), Positives = 58/127 (45%), Gaps = 12/127 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S P Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
E + R I HP ++ D+ +++L + ++ P+ LP S+
Sbjct: 56 KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKSATLNTYVQPVALP----SS 108
Query: 180 CIPISNL 186
C P +
Sbjct: 109 CAPAGTM 115
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/116 (31%), Positives = 58/116 (50%), Gaps = 9/116 (7%)
Query: 60 IVGGDE-AGFGSFPWQAYIRIGSSRC-GGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
IVGG + S P+Q + GS C GGSL+N VV+A HC ++ ++QV LG++
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCSYKS---RIQVRLGEHN 57
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
I+ +E + KI HP F + D+ +++L P +A + LP
Sbjct: 58 ID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSRVATVSLP 109
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRI----GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
I+GG EA S P+ A+++ RCGG LV + V+TA HC + VTLG
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC----QGSSINVTLGA 56
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ I E + R I P+ + P+ ++ +L+L+R ++ + P+ LP
Sbjct: 57 HNIKEQ-ERTQQFIPVKRPI---PHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLP 110
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 10/119 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCV--ARASARQVQVTLGDYV 117
I GG +A G FPWQ I +G + G+L+ V+TA H V + A + + +G
Sbjct: 1 IYGGQKAKPGDFPWQVLI-LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMG--- 56
Query: 118 INSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ P YT + + +H + D D+A+++L+ V +I PICLP K
Sbjct: 57 --TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDN-DIALIKLNNKVVINSNITPICLPRK 112
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 10/119 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCV--ARASARQVQVTLGDYV 117
I GG +A G FPWQ I +G + G+L+ V+TA H V + A + + +G
Sbjct: 1 IYGGQKAKPGDFPWQVLI-LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMG--- 56
Query: 118 INSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ P YT + + +H + D D+A+++L+ V +I PICLP K
Sbjct: 57 --TLKRLSPHYTQAWSEAVFIHEGYTHDAGFDN-DIALIKLNNKVVINSNITPICLPRK 112
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 42/119 (35%), Positives = 58/119 (48%), Gaps = 15/119 (12%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-----CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+ G EA G FP+QA + I CGGSL++ ++TA HCV A + V V LG
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVHDAVS--VVVYLG 58
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
SAV+ +I H F P DVA++++ V+Y +I PI LP
Sbjct: 59 -----SAVQYEGEAVVNSERIISHSMFN--PDTYLNDVALIKIPH-VEYTDNIQPIRLP 109
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 7/113 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG EA + P+ A +++ G CGG LV V++A HC+ A+ +VQV LG + +
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 119 NSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
+ +P P+ + V + HP + P +D+ +L+L P + P+
Sbjct: 61 S---QPEPSKRLYDVLRAVPHPDSR--PDTIDHDLLLLQLSEKATLGPAVRPL 108
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 45/127 (35%), Positives = 58/127 (45%), Gaps = 21/127 (16%)
Query: 69 GSFPWQ-AYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSAVEPLPA 127
S PW A R +CGG L++R V+TA HC + QV LG N+ +E P+
Sbjct: 13 NSQPWHVAVYRFNKYQCGGVLLDRNWVLTAAHCY----NDKYQVWLGK---NNFLEDEPS 65
Query: 128 YTFG-VRKINVHPYFKF------TPQ-ADRY--DVAVLRLDRPVQYMPHIAPICLPE--- 174
V K HP F TPQ D Y D+ +LRL +P + PI LP
Sbjct: 66 DQHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEEP 125
Query: 175 KGKSTCI 181
K STC+
Sbjct: 126 KLGSTCL 132
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 47.8 bits (112), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 15/127 (11%)
Query: 60 IVGGDEAGFGSFPWQAYIRI----GSSR---CGGSLVNRFHVVTAGHCVA-RASARQVQV 111
+VGG A G++PW ++I + R CGG L+N V+TA HC + ++
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 112 TLGDYVI----NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 167
G + N V+P P V +I +H K+ + D+A++++ PV P I
Sbjct: 61 IFGANEVVWGSNKPVKP-PLQERFVEEIIIHE--KYVSGLEINDIALIKITPPVPCGPFI 117
Query: 168 APICLPE 174
P CLP+
Sbjct: 118 GPGCLPQ 124
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 47.8 bits (112), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG EA + P+ A +++ G+ CGG LV V++A HC+ A+ +VQV LG + +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 119 NSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
+ +P P+ + V + HP + P +D+ +L+L P + P+
Sbjct: 61 S---QPEPSKRLYDVLRAVPHPDSQ--PDTIDHDLLLLQLSEKATLGPAVRPL 108
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 47.8 bits (112), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 13/121 (10%)
Query: 60 IVGGDEAGFGSFPWQAY---IRIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG+E S P+ AY +++G + CGG LV V+TA HC R + VTLG
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC----KGRSMTVTLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ I + E V K HP + P D+ +L+L R + + P+ LP
Sbjct: 57 AHNIKAKEE--TQQIIPVAKAIPHP--DYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPR 112
Query: 175 K 175
+
Sbjct: 113 R 113
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 47.8 bits (112), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 13/121 (10%)
Query: 60 IVGGDEAGFGSFPWQAY---IRIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG+E S P+ AY +++G + CGG LV V+TA HC R + VTLG
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC----KGRSMTVTLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ I + E V K HP + P D+ +L+L R + + P+ LP
Sbjct: 57 AHNIKAKEE--TQQIIPVAKAIPHP--DYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPR 112
Query: 175 K 175
+
Sbjct: 113 R 113
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 47.8 bits (112), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 34/113 (30%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG EA + P+ A +++ G+ CGG LV V++A HC+ A+ +VQV LG + +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 119 NSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
+ +P P+ + V + HP + P +D+ +L+L P + P+
Sbjct: 61 S---QPEPSKRLYDVLRAVPHPDSQ--PDTIDHDLLLLQLSEKATLGPAVRPL 108
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 47.8 bits (112), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 34/112 (30%), Positives = 57/112 (50%), Gaps = 5/112 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG EA + P+ A +++ G+ CGG LV V++A HC+ A+ +VQV LG + +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
S EP +R + P+ P +D+ +L+L P + P+
Sbjct: 61 -SQPEPSKRLYDVLRAV---PHPDSQPDTIDHDLLLLQLSEKATLGPAVRPL 108
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 47.8 bits (112), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 36/118 (30%), Positives = 51/118 (43%), Gaps = 10/118 (8%)
Query: 61 VGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
VGG A G FP+ I R G CGGSL+N V+TA HCV+ + Q+ G
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSRT 61
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S T + + VHP + + D+A+L+L + +I L G
Sbjct: 62 SG-----GITSSLSSVRVHPSYS----GNNNDLAILKLSTSIPSGGNIGYARLAASGS 110
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 47.4 bits (111), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 12/127 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG E S Q + G CGGSLVN VV+A HC +V+V LG++ I
Sbjct: 1 IVGGYECKAYSQAHQVSLNSGYHFCGGSLVNENWVVSAAHCY----KSRVEVRLGEHNIK 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKST 179
E + R I HP ++ D+ +++L +P ++ P+ LP ++
Sbjct: 57 -VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYVQPVALP----TS 108
Query: 180 CIPISNL 186
C P +
Sbjct: 109 CAPAGTM 115
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL+N VV+AGHC ++QV LG++ I
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCY----KSRIQVRLGEHNI- 55
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+E + KI HP ++ + D+ +++L ++ I LP
Sbjct: 56 EVLEGNEQF-INAAKIIRHP--QYDRKTLNNDIMLIKLSSRAVINARVSTISLP 106
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 36/115 (31%), Positives = 55/115 (47%), Gaps = 5/115 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIR-IGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG +A FP+ A I+ GS CGG+L++ V+TA C + V LG Y +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
E TF + ++ + Y PQ + D+ +L+LDR + + LP
Sbjct: 61 RRR-ERQSRQTFSISSMSENGY---DPQQNLNDLMLLQLDREANLTSSVTILPLP 111
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 46.6 bits (109), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 37/118 (31%), Positives = 55/118 (46%), Gaps = 12/118 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR----CGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
I+GG EA S P+ A++ +S CGG LV V+TA HC+ + + VTLG
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCLGSS----INVTLGA 56
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ N VR+ HP + A+ D+ +L+L R ++PI LP
Sbjct: 57 H--NIMERERTQQVIPVRRPIPHPDYNDETLAN--DIMLLKLTRKADITDKVSPINLP 110
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 46.6 bits (109), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 13/121 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-----CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG E+ S P+ AY+ I +S CGG L+ R V+TA HC R+ + VTLG
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS----ITVTLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ I E V K HP K+ +D+ +L+L + + P
Sbjct: 57 AHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 175 K 175
+
Sbjct: 113 Q 113
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 46.6 bits (109), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 8/114 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG S P+Q + G CGGSL++ VV+A HC ++QV LG++ N
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGYHFCGGSLISEQWVVSAAHCY----KTRIQVRLGEH--N 54
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
V KI HP K+ D+ +++L P ++ I LP
Sbjct: 55 IKVLEGNEQFINAAKIIRHP--KYNRDTLDNDIMLIKLSSPAVINARVSTISLP 106
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 46.6 bits (109), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 28/108 (25%), Positives = 49/108 (45%), Gaps = 11/108 (10%)
Query: 70 SFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSAVEPLPA 127
PWQ + G CGG ++ V+T C S +T+ Y ++ +PL
Sbjct: 104 DLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKC----SLLHRNITVKTYFNRTSQDPLM- 158
Query: 128 YTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
++ +VH + ++ A D+++L L+ P+Q P+C PEK
Sbjct: 159 ----IKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEK 202
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 46.6 bits (109), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 13/119 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-----CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG E+ S P+ A++ I + + CGG L++R V+TA HC R++ V LG
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHC----KGREITVILG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
+ + V K +H + P + +D+ +L+L++ V+ P + + LP
Sbjct: 57 AHDVRK--RESTQQKIKVEKQIIHESYNSVP--NLHDIMLLKLEKKVELTPAVNVVPLP 111
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 28/108 (25%), Positives = 49/108 (45%), Gaps = 11/108 (10%)
Query: 70 SFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSAVEPLPA 127
PWQ + G CGG ++ V+T C S +T+ Y ++ +PL
Sbjct: 63 DLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKC----SLLHRNITVKTYFNRTSQDPLM- 117
Query: 128 YTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
++ +VH + ++ A D+++L L+ P+Q P+C PEK
Sbjct: 118 ----IKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEK 161
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/126 (32%), Positives = 54/126 (42%), Gaps = 16/126 (12%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+VGG S PWQ + CGG L++R V+TA HC Q +V LG +
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHCY----VDQYEVWLGKNKL 56
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFT--------PQAD-RYDVAVLRLDRPVQYMPHIAP 169
EP + V K HP F + P AD D+ +LRL +P + P
Sbjct: 57 FQE-EPSAQHRL-VSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKP 114
Query: 170 ICLPEK 175
I LP K
Sbjct: 115 IALPTK 120
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 13/121 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-----CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG E S P+ AY+ I +S CGG L+ R V+TA HC R+ + VTLG
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS----ITVTLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ I E V K HP K+ +D+ +L+L + + P
Sbjct: 57 AHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 175 K 175
+
Sbjct: 113 Q 113
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 18/135 (13%)
Query: 60 IVGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG E S PWQA + + +CGG LV+R V+TA HC+ + Q+ LG + +
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCI----SDNYQLWLGRHNL 56
Query: 119 ----NSAVEPLPAYTFGVRKINVHPYFKFTPQADR---YDVAVLRLDRPVQYMPHIA--- 168
N+A + +F N+ T QAD +D+ +LRL P +
Sbjct: 57 FDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVV 116
Query: 169 --PICLPEKGKSTCI 181
P PE G STC+
Sbjct: 117 ELPTEEPEVG-STCL 130
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 13/121 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-----CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG E S P+ AY+ I +S CGG L+ R V+TA HC R+ + VTLG
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS----ITVTLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ I E V K HP K+ +D+ +L+L + + P
Sbjct: 57 AHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 175 K 175
+
Sbjct: 113 Q 113
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 36/122 (29%), Positives = 53/122 (43%), Gaps = 13/122 (10%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR-----CGGSLVNRFHVVTAGHCVARASARQVQVTL 113
I+GG E S P+ AY+ I +S CGG L+ R V+TA HC R+ + VTL
Sbjct: 2 EIIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS----ITVTL 57
Query: 114 GDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
G + I E V K HP K+ +D+ +L+L + + P
Sbjct: 58 GAHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLTLAVGTLPFP 113
Query: 174 EK 175
+
Sbjct: 114 SQ 115
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 13/121 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-----CGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG E S P+ AY+ I +S CGG L+ R V+TA HC R+ + VTLG
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS----ITVTLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ I E V K HP K+ +D+ +L+L + + P
Sbjct: 57 AHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPS 112
Query: 175 K 175
+
Sbjct: 113 Q 113
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/133 (28%), Positives = 57/133 (42%), Gaps = 19/133 (14%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+ G E S PWQA + G CGG LV V+TA HC ++ V LGD+ +
Sbjct: 1 ILEGRECIPHSQPWQAALFQGERLICGGVLVGDRWVLTAAHC----KKQKYSVRLGDHSL 56
Query: 119 NSAVEPLPAYTFGVRKINVHP-YFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S + P V + HP Y P+ +D+ ++RL + P
Sbjct: 57 QSRDQ--PEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKP-------- 106
Query: 178 STCIPISNLLPKL 190
+ ++NL PK+
Sbjct: 107 ---VQLANLCPKV 116
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 55/131 (41%), Gaps = 20/131 (15%)
Query: 60 IVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARA------------- 104
I G A G+ PW A + G CGGSL+ +VTA HC+ ++
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDL 60
Query: 105 -SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQY 163
S ++ LG + + E GV+ +HP ++ P DVA++ L
Sbjct: 61 LSPSDFKIILGKHWRLRSDE--NEQHLGVKHTTLHP--QYDPNTFENDVALVELLESPVL 116
Query: 164 MPHIAPICLPE 174
+ PICLPE
Sbjct: 117 NAFVMPICLPE 127
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 44.3 bits (103), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 40/117 (34%), Positives = 55/117 (47%), Gaps = 7/117 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG EA S+P QA + I CGGSL++ ++TA HC+ A V V LG + I
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGF--VDVVLGAHNI 58
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ T VH + ++ D+AV+RL PV IA + LP
Sbjct: 59 RE--DEATQVTIQSTDFTVHENYNSFVISN--DIAVIRLPVPVTLTAAIATVGLPST 111
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 43.9 bits (102), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 54/115 (46%), Gaps = 5/115 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIR-IGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG +A FP+ A I+ G CGG+L++ V+TA C + V LG Y +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
E TF + ++ + Y PQ + D+ +L+LDR + + LP
Sbjct: 61 RRR-ERQSRQTFSISSMSENGY---DPQQNLNDLMLLQLDREANLTSSVTILPLP 111
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 43.9 bits (102), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 54/115 (46%), Gaps = 5/115 (4%)
Query: 60 IVGGDEAGFGSFPWQAYIR-IGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG +A FP+ A I+ G CGG+L++ V+TA C + V LG Y +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
E TF + ++ + Y PQ + D+ +L+LDR + + LP
Sbjct: 61 RRR-ERQSRQTFSISSMSENGY---DPQQNLNDLMLLQLDREANLTSSVTILPLP 111
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 43.5 bits (101), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 12/102 (11%)
Query: 60 IVGGDEAGFGSFPWQAYIRI----GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
I+GG E+ S P+ AY++I G SRCGG LV V+TA HC + VTLG
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCW----GSNINVTLGA 56
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
+ I T R+ HP ++ + + D+ +L+L
Sbjct: 57 HNIQRRENTQQHIT--ARRAIRHP--QYNQRTIQNDIMLLQL 94
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 43.5 bits (101), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 32/50 (64%), Gaps = 1/50 (2%)
Query: 132 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKSTCI 181
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ + +
Sbjct: 8 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASL 56
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 43.5 bits (101), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 12/103 (11%)
Query: 60 IVGGDEAGFGSFPWQAYIRI----GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
I+GG E+ S P+ AY++I G SRCGG LV V+TA HC + VTLG
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCW----GSNINVTLGA 56
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLD 158
+ I T R+ HP ++ + + D+ +L+L
Sbjct: 57 HNIQRRENTQQHIT--ARRAIRHP--QYNQRTIQNDIMLLQLS 95
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 11/120 (9%)
Query: 58 RRIVGGDEAGFGSFPWQA-YIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
+RI+GG GSFPWQA I + G +L+N ++T +A+ +++ +
Sbjct: 101 QRIMGGSLDAKGSFPWQAKMISHHNLTSGATLINEQWLLT--------TAKNLRLGHKND 152
Query: 117 VINSAVEP-LPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ P L Y +++ + F P D+ +++L + V + PICLP K
Sbjct: 153 TKAKDIAPTLRLYVGKKQEVEIEKVI-FHPDNSTVDIGLIKLKQKVPVNERVMPICLPSK 211
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/126 (27%), Positives = 54/126 (42%), Gaps = 16/126 (12%)
Query: 60 IVGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG E S PWQ + G + CGG LV+ V+TA HC+ S + LG + +
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKSV----ILLGRHSL 56
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRY---------DVAVLRLDRPVQYMPHIAP 169
+ F V HP + + +R+ D+ +LRL P + +
Sbjct: 57 FHPED--TGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKV 114
Query: 170 ICLPEK 175
+ LP +
Sbjct: 115 MDLPTQ 120
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 46/142 (32%), Positives = 60/142 (42%), Gaps = 23/142 (16%)
Query: 47 CGVSVKNQGAQRRIVGGDEAGFGSFPWQAYIRIGSSR-------CGGSLVNRFHVVTAGH 99
CG+ +Q Q RI GG A S PWQA I R CGG L++ +++A H
Sbjct: 2 CGLRQYSQ-PQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAH 60
Query: 100 CV-ARASARQVQVTLG-DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRY--DVAVL 155
C R + V LG Y + E F V K VH F D Y D+A+L
Sbjct: 61 CFQERFPPHHLTVILGRTYRVVPGEE---EQKFEVEKYIVHKEF----DDDTYDNDIALL 113
Query: 156 RL----DRPVQYMPHIAPICLP 173
+L R Q + +CLP
Sbjct: 114 QLKSDSSRCAQESSVVRTVCLP 135
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 43/135 (31%), Positives = 56/135 (41%), Gaps = 19/135 (14%)
Query: 60 IVGGDEAGFGSFPWQ-AYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG + S PW A R CGG L++ V+TA HC +V LG +
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCY----DDNYKVWLGKNNL 56
Query: 119 NSAVEPLPAYTFGVRKINVHPYF---------KFTPQADRYDVAVLRLDRPVQYMPHIAP 169
EP + F V K HP F +F D+ +LRL +P + P
Sbjct: 57 FKD-EPSAQHRF-VSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKP 114
Query: 170 ICLPE---KGKSTCI 181
I LP K STC+
Sbjct: 115 ITLPTEEPKLGSTCL 129
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 55/128 (42%), Gaps = 15/128 (11%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGS-----SRCGGSLVNRFHVVTAGHCVARASARQVQVTLG 114
I+GG E + P+ AY+ I + S C G L+ R V+TA HC R+ + V LG
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAGRS----ITVLLG 56
Query: 115 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 174
+ N V+ V K HP K+ + D+ +L+L + LP
Sbjct: 57 AH--NKKVKEDTWQKLEVEKQFPHP--KYDDRLVLNDIMLLKLKEKANLTLGVG--TLPI 110
Query: 175 KGKSTCIP 182
KS IP
Sbjct: 111 SAKSNSIP 118
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/134 (29%), Positives = 59/134 (44%), Gaps = 19/134 (14%)
Query: 60 IVGGDEAGFGSFPWQ-AYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG E S PWQ A G +CGG LV+ V+TA HC+ + Q+ LG +
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCM----SDDYQIWLGRH-- 54
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRY---------DVAVLRLDRPVQYMPHIAP 169
N + + A V + P F + +Y D+ +LRL +P + +
Sbjct: 55 NLSKDEDTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAVKI 114
Query: 170 ICLPE---KGKSTC 180
+ LP K STC
Sbjct: 115 LDLPTQEPKLGSTC 128
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG+E S P+ + + + C G+L+ + V+TA HC ++ QV LG + I
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLN---KRSQVILGAHSI 57
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 176
EP ++ PY + P D+ +L+L + ++ + LP+KG
Sbjct: 58 TRE-EPTKQIMLVKKEF---PYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKG 111
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 8/118 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIG-SSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG+E S P+ + + + C G+L+ + V+TA HC ++ QV LG + I
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLN---KRSQVILGAHSI 57
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 176
EP ++ PY + P D+ +L+L + ++ + LP+KG
Sbjct: 58 TRE-EPTKQIMLVKKEF---PYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKG 111
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 41.2 bits (95), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 8/102 (7%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
+VGG A G FP+ + +G CGG+L + V+TA HCV+ S +T
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG---CGGALYAQDIVLTAAHCVS-GSGNNTSIT----ATG 52
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
V+ + VR V FT + D A+++L +P+
Sbjct: 53 GVVDLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPI 94
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 41.2 bits (95), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQV-QVTLGDYVINSAVEPLPAYT 129
PW I+ S C G+L++ V+TA HC + + +V +GD E
Sbjct: 244 PWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKE------ 297
Query: 130 FGVRKINVHPYFKFTPQADR-------YDVAVLRLDRPVQYMPHIAPICLP 173
F + K + P F + ++ D+A+L+L + V+ H PICLP
Sbjct: 298 FLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP 348
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 41.2 bits (95), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 12/118 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI- 118
IVGG E S Q + G CGGSLV++ VV+A HC ++V LG++ I
Sbjct: 1 IVGGYECTKHSQAHQVSLNSGYHFCGGSLVSKDWVVSAAHCYKSV----LRVRLGEHHIR 56
Query: 119 -NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
N E + + +R HP ++ D+ +++L +P ++ + LP +
Sbjct: 57 VNEGTEQYISSSSVIR----HP--NYSSYNINNDIMLIKLTKPATLNQYVHAVALPTE 108
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 41.2 bits (95), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 15/111 (13%)
Query: 72 PWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQV-QVTLGDYVINSAVEPLPAYT 129
PW I+ S C G+L++ V+TA HC + + +V +GD E
Sbjct: 236 PWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSLWRVNVGDPKSQWGKE------ 289
Query: 130 FGVRKINVHPYFKFTPQADR-------YDVAVLRLDRPVQYMPHIAPICLP 173
F + K + P F + ++ D+A+L+L + V+ H PICLP
Sbjct: 290 FLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLP 340
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 40.8 bits (94), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 32/112 (28%), Positives = 48/112 (42%), Gaps = 10/112 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
I+GGDE + + SR CGG+L+N+ V+TA HC + ++ LG
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHC----DRKNFRIKLG-- 54
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 168
++S P V K D+ ++RLD PV+ HIA
Sbjct: 55 -MHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHIA 105
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 9/113 (7%)
Query: 60 IVGGDEAGFGSFPWQA--YIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
I+ G + + PWQA +R CG LV+ ++TA HC + +V LG Y
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKV----FRVRLGHYS 56
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
++ E GV+ I P+ ++ D+ +++L+R ++ + PI
Sbjct: 57 LSPVYESGQQMFQGVKSI---PHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPI 106
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 37/126 (29%), Positives = 57/126 (45%), Gaps = 13/126 (10%)
Query: 59 RIVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVT 112
+I+GG+ + PW A I R GS CGGSL++ V++A HC ++ +
Sbjct: 23 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIV 82
Query: 113 -LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHI 167
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 83 YLGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTI 140
Query: 168 APICLP 173
ICLP
Sbjct: 141 QTICLP 146
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 40.0 bits (92), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIA 168
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 169 PICLP 173
ICLP
Sbjct: 119 TICLP 123
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/119 (26%), Positives = 53/119 (44%), Gaps = 6/119 (5%)
Query: 59 RIVGGDEAGFGSFPWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQV-QVTLGDY 116
I+GG E S P+ A I+ G CGG L++ V+TA HC R + Q V LG +
Sbjct: 2 EIIGGKEVSPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSPTVVLGAH 61
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
++ T ++K P+ + T D+ +++L + H+ + + K
Sbjct: 62 SLSK--NEASKQTLEIKKFI--PFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRSK 116
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 20/41 (48%), Positives = 24/41 (58%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHC 100
IVGG S P+Q + GS CGGSL+N VV+A HC
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHC 41
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIA 168
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 169 PICLP 173
ICLP
Sbjct: 119 TICLP 123
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIA 168
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 169 PICLP 173
ICLP
Sbjct: 119 TICLP 123
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVT- 112
I+GG+ + PW A I R GS CGGSL++ V++A HC ++ +
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIA 168
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 169 PICLP 173
ICLP
Sbjct: 119 TICLP 123
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIA 168
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 169 PICLP 173
ICLP
Sbjct: 119 TICLP 123
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIA 168
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 169 PICLP 173
ICLP
Sbjct: 119 TICLP 123
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 23/123 (18%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSS-RCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+ G GS PWQ + G+ CGG LVN V+TA HC + +Y +
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC-----------KMNEYTV 49
Query: 119 NSAVEPLPAYTFGVR---KINVHPYFK---FTPQADRYDVAVLRLDRPVQYMPHIAPICL 172
+ L + T G R +I F+ ++ Q D+ +++L+ + + + L
Sbjct: 50 H-----LGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRL 104
Query: 173 PEK 175
P +
Sbjct: 105 PSR 107
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPHIA 168
LG +NS + F V + +H + A D+A+L++ R Q I
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 169 PICLP 173
ICLP
Sbjct: 119 TICLP 123
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 23/123 (18%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSS-RCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+ G GS PWQ + G+ CGG LVN V+TA HC + +Y +
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC-----------KMNEYTV 49
Query: 119 NSAVEPLPAYTFGVR---KINVHPYFK---FTPQADRYDVAVLRLDRPVQYMPHIAPICL 172
+ L + T G R +I F+ ++ Q D+ +++L+ + + + L
Sbjct: 50 H-----LGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRL 104
Query: 173 PEK 175
P +
Sbjct: 105 PSR 107
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/86 (37%), Positives = 38/86 (44%), Gaps = 7/86 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI-RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG E S PWQ I S +CGG LVN V+TA HC +V LG +
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHC----KNDNYEVWLGRH-- 54
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFT 144
N A FGV HP F +
Sbjct: 55 NLFENENTAQFFGVTADFPHPGFNLS 80
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 12/106 (11%)
Query: 62 GGDEAGFGSFPWQAYIRI----GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
GG++ PW +R S CGG++++++ V+TA HCV + +
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETIVIQYES-- 59
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQAD-RYDVAVLRLDRPVQ 162
N +P + + H Y F Q D+A+L L RP++
Sbjct: 60 TNLWEDPGKSDPY-----VSHVYLSFYRQETMENDIAILELSRPLK 100
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 41/129 (31%), Positives = 53/129 (41%), Gaps = 22/129 (17%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-------CGGSLVNRFHVVTAGHCV-ARASARQVQV 111
I GG A S PWQA I R CGG L++ +++A HC R + V
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 112 TLG-DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRY--DVAVLRL----DRPVQYM 164
LG Y + E F V K VH F D Y D+A+L+L R Q
Sbjct: 61 ILGRTYRVVPGEE---EQKFEVEKYIVHKEF----DDDTYDNDIALLQLKSDSSRCAQES 113
Query: 165 PHIAPICLP 173
+ +CLP
Sbjct: 114 SVVRTVCLP 122
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 50/113 (44%), Gaps = 9/113 (7%)
Query: 59 RIVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
++V G S P+QA + G CGG L++ V+TA HC +QV LG +
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLGKH- 55
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
N + V + +HP + + D+ +LRL RP + I P+
Sbjct: 56 -NLRQQESSQEQSSVVRAVIHP--DYDAASHDQDIMLLRLARPAKLSELIQPL 105
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 8/110 (7%)
Query: 60 IVGGDEAGFGSFPWQ-AYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
++GG+E + A+ CGG+L+N VVTA HC + Q+ LG V
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC----DSTDFQMQLG--VH 54
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 168
+ V T ++ + P D+ D+ +++LD+P+ HIA
Sbjct: 55 SKKVLNEDEQTRNPKEKFICPNKNNNEVLDK-DIMLIKLDKPISNSKHIA 103
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 8/110 (7%)
Query: 60 IVGGDEAGFGSFPWQ-AYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
++GG+E + A+ CGG+L+N VVTA HC + Q+ LG V
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC----DSTNFQMQLG--VH 54
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 168
+ V T ++ + P D+ D+ +++LD+P+ HIA
Sbjct: 55 SKKVLNEDEQTRNPKEKFICPNKNNNEVLDK-DIMLIKLDKPISNSKHIA 103
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 9/112 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+V G S P+QA + G CGG L++ V+TA HC +QV LG + +
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLGKHNL 56
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
E + VR + +HP + + D+ +LRL RP + I P+
Sbjct: 57 RQR-ESSQEQSSVVRAV-IHP--DYDAASHDQDIMLLRLARPAKLSELIQPL 104
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/112 (28%), Positives = 49/112 (43%), Gaps = 9/112 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
+V G S P+QA + G CGG L++ V+TA HC +QV LG +
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC----KKPNLQVFLGKH-- 54
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 170
N + V + +HP + + D+ +LRL RP + I P+
Sbjct: 55 NLGQQESSQEQSSVVRAVIHP--DYDAASHDQDIMLLRLARPAKLSELIQPL 104
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
+VGG A G FP+ + +G CGG+L + V+TA HCV+ S +T V++
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG---CGGALYAQDIVLTAAHCVS-GSGNNTSITATGGVVD 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
++ A K+ P + T + D A+++L +P+
Sbjct: 57 --LQSSSAVKVRSTKVLQAPGYNGTGK----DWALIKLAQPI 92
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
+VGG A G FP+ + +G CGG+L + V+TA HCV+ S +T V++
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG---CGGALYAQDIVLTAAHCVS-GSGNNTSITATGGVVD 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
++ A K+ P + T + D A+++L +P+
Sbjct: 57 --LQSSSAVKVRSTKVLQAPGYNGTGK----DWALIKLAQPI 92
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
+VGG A G FP+ + +G CGG+L + V+TA HCV+ S +T V++
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG---CGGALYAQDIVLTAAHCVS-GSGNNTSITATGGVVD 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
++ A K+ P + T + D A+++L +P+
Sbjct: 57 --LQSSSAVKVRSTKVLQAPGYNGTGK----DWALIKLAQPI 92
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 37.0 bits (84), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 9/106 (8%)
Query: 59 RIVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHCVARASARQVQVT 112
+I+GG+ + PW A I R GS CGGSL++ V++A HC ++ +
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIV 74
Query: 113 -LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 75 YLGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 118
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 37.0 bits (84), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
+VGG A G FP+ + +G CGG+L + V+TA HCV+ S +T V++
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG---CGGALYAQDIVLTAAHCVS-GSGNNTSITATGGVVD 56
Query: 120 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
++ A K+ P + T + D A+++L +P+
Sbjct: 57 --LQSGAAVKVRSTKVLQAPGYNGTGK----DWALIKLAQPI 92
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 36.6 bits (83), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 29/104 (27%), Positives = 45/104 (43%), Gaps = 7/104 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
+VGG A G FP+ + CGG+L + V+TA HCV+ S +T
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVS-GSGNNTSIT----A 55
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
V+ + VR V FT + D A+++L +P+
Sbjct: 56 TGGVVDLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPI 99
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 29/104 (27%), Positives = 45/104 (43%), Gaps = 7/104 (6%)
Query: 60 IVGGDEAGFGSFPWQAYI--RIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYV 117
+VGG A G FP+ + CGG+L + V+TA HCV+ S +T
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVS-GSGNNTSIT----A 55
Query: 118 INSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPV 161
V+ + VR V FT + D A+++L +P+
Sbjct: 56 TGGVVDLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPI 99
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 103
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 55/135 (40%), Gaps = 21/135 (15%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVIN 119
IVGG + S PWQ + I CGG L++ V+TA HC + QV LG N
Sbjct: 1 IVGGYKCEKNSQPWQVAV-INEYLCGGVLIDPSWVITAAHCY----SNNYQVLLGR---N 52
Query: 120 SAVEPLP-AYTFGVRKINVHP-YFKFTPQADRY--------DVAVLRLDRPVQYMPHIAP 169
+ + P A VR+ HP Y D D+ +L L P +
Sbjct: 53 NLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGGVKV 112
Query: 170 ICLPEKG---KSTCI 181
I LP K STC+
Sbjct: 113 IDLPTKEPKVGSTCL 127
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 36.2 bits (82), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 103
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 103
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 103
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 103
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 103
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 35.8 bits (81), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 9/105 (8%)
Query: 60 IVGGDEAGFGSFPWQAYI----RIGSSR--CGGSLVNRFHVVTAGHC-VARASARQVQVT 112
I+GG+ + PW A I R GS CGGSL++ V++A HC + V
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 113 LGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL 157
LG +NS + F V + +H + A D+A+L++
Sbjct: 61 LGRSRLNSNTQ--GEMKFEVENLILHKDYSADTLAHHNDIALLKI 103
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 35.0 bits (79), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 3/45 (6%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCV 101
IV G +A G PWQ + S + CG SL++ V+TA HC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 35.0 bits (79), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 12/112 (10%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR---CGGSLVNRFHVVTAGHCVARASARQVQVTLGDY 116
+ GGDE ++ + + +S CGG+L+N+ VVTA HC + Q+ G
Sbjct: 1 VFGGDECNINEH--RSLVVLFNSNGFLCGGTLINQDWVVTAAHC----DSNNFQLLFG-- 52
Query: 117 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 168
V + + T ++ P K + D+ D+ +++LD V HIA
Sbjct: 53 VHSKKILNEDEQTRDPKEKFFCPNRKKDDEVDK-DIMLIKLDSSVSNSEHIA 103
>pdb|1P3C|A Chain A, Glutamyl Endopeptidase From Bacillus Intermedius
pdb|1P3E|A Chain A, Structure Of Glu Endopeptidase In Complex With Mpd
Length = 215
Score = 34.3 bits (77), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 12/92 (13%)
Query: 75 AYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSAVEPLPAYTFGVR- 133
AYI G S C G+L+ ++T GHCV ++R Y +V P + V
Sbjct: 23 AYITFGGSSCTGTLIAPNKILTNGHCVYNTASRS-------YSAKGSVYPGMNDSTAVNG 75
Query: 134 KINVHPYF----KFTPQADRYDVAVLRLDRPV 161
N+ ++ A +YD AV++ D +
Sbjct: 76 SANMTEFYVPSGYINTGASQYDFAVIKTDTNI 107
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 34.3 bits (77), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 34/118 (28%), Positives = 48/118 (40%), Gaps = 15/118 (12%)
Query: 60 IVGGDEAGFGSFPWQAYIR--IGSSRCGGSLVNRFHVVTAGHCVARASA--RQVQVTLGD 115
+VGG G+ PW +R G CGGSLV ++TA C + +V LG
Sbjct: 1 VVGGHP---GNSPWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSCHMPLTGYEVWLGT 57
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP 173
N P + G + P K + +L+L+R V +A ICLP
Sbjct: 58 LFQN------PQH--GEPSLQRVPVAKMVCGPSGSQLVLLKLERSVTLNQRVALICLP 107
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 33.5 bits (75), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 9/104 (8%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSS-RCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+GG ++ PW + + CGGS++ V+TA CV + + G
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCVDGTKPSDISIHYG---- 56
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 162
S+ + +KI + Y T Q + AV+ + P++
Sbjct: 57 -SSYRTTKGTSVMAKKIYIVRYHPLTMQNNY---AVIETEMPIK 96
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 18/136 (13%)
Query: 60 IVGGDEAGFGSFPWQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
I+ G++ S PWQA + + + C G LV+ V++A HC + + LG + +
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNS----YTIGLGLHSL 56
Query: 119 NSAVEP---LPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICL--- 172
+ EP + + VR HP + A+ D+ +++LD V I I +
Sbjct: 57 EADQEPGSQMVEASLSVR----HPEYNRPLLAN--DLMLIKLDESVSESDTIRSISIASQ 110
Query: 173 -PEKGKSTCIPISNLL 187
P G S + LL
Sbjct: 111 CPTAGNSCLVSGWGLL 126
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 32.0 bits (71), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 29/110 (26%), Positives = 45/110 (40%), Gaps = 8/110 (7%)
Query: 60 IVGGDEAGFGSF-PWQAYIRIGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
++GGDE A+ C G+L+N V+TA HC Q+ LG V
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHC----DNTNFQMKLG--VH 54
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 168
+ V T ++ + P K D+ D+ +++LD V HI
Sbjct: 55 SKKVLNEDEQTRNPKEKFICPNKKNDEVLDK-DIMLIKLDSRVSNSEHIV 103
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 31.6 bits (70), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG A ++P+ +++ G CG +L+ V++A HCVA + R V+V LG + +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S EP F V++I + Y P D+ +L+L+ ++ LP +G+
Sbjct: 61 -SRREP-TRQVFAVQRIFENGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 31.6 bits (70), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG A ++P+ +++ G CG +L+ V++A HCVA + R V+V LG + +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S EP F V++I + Y P D+ +L+L+ ++ LP +G+
Sbjct: 61 -SRREP-TRQVFAVQRIFENGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 31.6 bits (70), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG A ++P+ +++ G CG +L+ V++A HCVA + R V+V LG + +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S EP F V++I + Y P D+ +L+L+ ++ LP +G+
Sbjct: 61 -SRREP-TRQVFAVQRIFENGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 31.2 bits (69), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 23/107 (21%), Positives = 44/107 (41%), Gaps = 9/107 (8%)
Query: 73 WQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSAVEPLPAYTFG 131
W +R + CGGSL+ V+TA C + + LG + ++ +
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCKQVLN 72
Query: 132 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKS 178
V ++ + P+ D+ +++L RP ++ I LP G +
Sbjct: 73 VSQL------VYGPEGS--DLVLMKLARPAVLDDFVSTIDLPNYGST 111
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 31.2 bits (69), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 23/107 (21%), Positives = 44/107 (41%), Gaps = 9/107 (8%)
Query: 73 WQAYIRIGSSR-CGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVINSAVEPLPAYTFG 131
W +R + CGGSL+ V+TA C + + LG + ++ +
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCKQVLN 72
Query: 132 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGKS 178
V ++ + P+ D+ +++L RP ++ I LP G +
Sbjct: 73 VSQL------VYGPEGS--DLVLMKLARPAVLDDFVSTIDLPNYGST 111
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 31.2 bits (69), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 6/119 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG A ++P+ +++ G CG +L+ V++A HCVA + R V+V LG + +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S EP F V++I Y P D+ +L+L+ ++ LP +G+
Sbjct: 61 -SRREP-TRQVFAVQRIFEDGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 30.8 bits (68), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 6/119 (5%)
Query: 60 IVGGDEAGFGSFPWQAYIRI-GSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGDYVI 118
IVGG A ++P+ +++ G CG +L+ V++A HCVA + R V+V LG + +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNL 60
Query: 119 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGK 177
S EP F V++I Y P D+ +L+L+ ++ LP +G+
Sbjct: 61 -SRREP-TRQVFAVQRIFEDGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 30.8 bits (68), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 31/131 (23%), Positives = 51/131 (38%), Gaps = 12/131 (9%)
Query: 60 IVGGDEAGFGSFPWQAYIR----IGSSRCGGSLVNRFHVVTAGHCVARASARQVQVTLGD 115
++GG A G FPWQ + S CG SL++ ++A HCV ++V G
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIAGL 60
Query: 116 YVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 175
+ + T V +H + + D+A+L L + +I LP
Sbjct: 61 W---QQSDTSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPAN 117
Query: 176 GK-----STCI 181
+TC+
Sbjct: 118 NNNDYAGTTCV 128
>pdb|1AOC|A Chain A, Japanese Horseshoe Crab Coagulogen
pdb|1AOC|B Chain B, Japanese Horseshoe Crab Coagulogen
Length = 175
Score = 27.3 bits (59), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 15/31 (48%)
Query: 55 GAQRRIVGGDEAGFGSFPWQAYIRIGSSRCG 85
G R IV AGF WQ R GS+ CG
Sbjct: 105 GEFRVIVQAPRAGFRQCVWQHKCRFGSNSCG 135
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.139 0.443
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 6,041,581
Number of Sequences: 62578
Number of extensions: 238606
Number of successful extensions: 1155
Number of sequences better than 100.0: 350
Number of HSP's better than 100.0 without gapping: 293
Number of HSP's successfully gapped in prelim test: 57
Number of HSP's that attempted gapping in prelim test: 545
Number of HSP's gapped (non-prelim): 351
length of query: 194
length of database: 14,973,337
effective HSP length: 94
effective length of query: 100
effective length of database: 9,091,005
effective search space: 909100500
effective search space used: 909100500
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 49 (23.5 bits)